US2008526A
(en)
|
1932-11-03 |
1935-07-16 |
Wappler Frederick Charles |
Method and means for treating living tissue
|
US3467096A
(en)
|
1966-04-12 |
1969-09-16 |
Ferrell S Horn |
Multiple hypodermic syringe arrangement
|
BE757653A
(fr)
|
1969-10-21 |
1971-04-16 |
Ugine Kuhlmann |
Nouveaux medicaments derives d'acides nucleiques et procedes pour leur preparation
|
BE786542A
(fr)
|
1971-07-22 |
1973-01-22 |
Dow Corning |
Dispositif d'aspiration permettant d'obtenir des echantillons de cellules
|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
US4411657A
(en)
|
1980-05-19 |
1983-10-25 |
Anibal Galindo |
Hypodermic needle
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
US4474569A
(en)
|
1982-06-28 |
1984-10-02 |
Denver Surgical Developments, Inc. |
Antenatal shunt
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4579849A
(en)
|
1984-04-06 |
1986-04-01 |
Merck & Co., Inc. |
N-alkylguanine acyclonucleosides as antiviral agents
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
US5116943A
(en)
|
1985-01-18 |
1992-05-26 |
Cetus Corporation |
Oxidation-resistant muteins of Il-2 and other protein
|
CA1288073C
(fr)
|
1985-03-07 |
1991-08-27 |
Paul G. Ahlquist |
Vecteur de transformation de l'arn
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
EP0204401A1
(fr)
|
1985-04-09 |
1986-12-10 |
Biogen, Inc. |
Méthode d'amélioration du rendement de polypeptides produits dans une cellule d'hôte par stabilisation de mARN
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
US4879111A
(en)
|
1986-04-17 |
1989-11-07 |
Cetus Corporation |
Treatment of infections with lymphokines
|
CA1283827C
(fr)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Dispositif pour l'injection de formules liquides
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
WO1989001050A1
(fr)
|
1987-07-31 |
1989-02-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Accroissement selectif de sequences de polynucleotides cibles
|
US6090591A
(en)
|
1987-07-31 |
2000-07-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Selective amplification of target polynucleotide sequences
|
EP0359789B1
(fr)
|
1988-01-21 |
1993-08-04 |
Genentech, Inc. |
Amplification et detection de sequences d'acides nucleiques
|
CA1340807C
(fr)
|
1988-02-24 |
1999-11-02 |
Lawrence T. Malek |
Procede d'amplification d'une sequence d'acide nucleique
|
JP2650159B2
(ja)
|
1988-02-24 |
1997-09-03 |
アクゾ・ノベル・エヌ・ベー |
核酸増幅方法
|
WO1989007947A1
(fr)
|
1988-03-04 |
1989-09-08 |
Cancer Research Campaign Technology Limited |
Ameliorations dans le domaine des antigenes
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
AU631545B2
(en)
|
1988-04-15 |
1992-12-03 |
Protein Design Labs, Inc. |
Il-2 receptor-specific chimeric antibodies
|
US5021335A
(en)
|
1988-06-17 |
1991-06-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
In situ transcription in cells and tissues
|
US5168038A
(en)
|
1988-06-17 |
1992-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
In situ transcription in cells and tissues
|
US5130238A
(en)
|
1988-06-24 |
1992-07-14 |
Cangene Corporation |
Enhanced nucleic acid amplification process
|
US5759802A
(en)
|
1988-10-26 |
1998-06-02 |
Tonen Corporation |
Production of human serum alubumin A
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
DE69032284T2
(de)
|
1989-03-21 |
1998-10-08 |
Vical, Inc., San Diego, Calif. |
Expression von exogenen polynukleotidsequenzen in wirbeltieren
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US6867195B1
(en)
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
US6673776B1
(en)
|
1989-03-21 |
2004-01-06 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
US5012818A
(en)
|
1989-05-04 |
1991-05-07 |
Joishy Suresh K |
Two in one bone marrow surgical needle
|
IE66597B1
(en)
|
1989-05-10 |
1996-01-24 |
Akzo Nv |
Method for the synthesis of ribonucleic acid (RNA)
|
US5332671A
(en)
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US5240855A
(en)
|
1989-05-12 |
1993-08-31 |
Pioneer Hi-Bred International, Inc. |
Particle gun
|
CA2020958C
(fr)
|
1989-07-11 |
2005-01-11 |
Daniel L. Kacian |
Methodes d'amplification de sequences d'acide nucleique
|
US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
NO904633L
(no)
|
1989-11-09 |
1991-05-10 |
Molecular Diagnostics Inc |
Amplifikasjon av nukleinsyrer ved transkriberbar haarnaalsprobe.
|
US5215899A
(en)
|
1989-11-09 |
1993-06-01 |
Miles Inc. |
Nucleic acid amplification employing ligatable hairpin probe and transcription
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
US5697901A
(en)
|
1989-12-14 |
1997-12-16 |
Elof Eriksson |
Gene delivery by microneedle injection
|
US5194370A
(en)
|
1990-05-16 |
1993-03-16 |
Life Technologies, Inc. |
Promoter ligation activated transcription amplification of nucleic acid sequences
|
EP0542874A4
(en)
|
1990-07-25 |
1994-05-11 |
Syngene Inc |
Circular extension for generating multiple nucleic acid complements
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
US6140496A
(en)
|
1990-10-09 |
2000-10-31 |
Benner; Steven Albert |
Precursors for deoxyribonucleotides containing non-standard nucleosides
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
US6100024A
(en)
|
1991-02-08 |
2000-08-08 |
Promega Corporation |
Methods and compositions for nucleic acid detection by target extension and probe amplification
|
DK0610201T4
(da)
|
1991-03-18 |
2008-02-04 |
Centocor Inc |
Monoklonale og kimære antistoffer, der er specifikke for human tumornekrosefaktor
|
US5426180A
(en)
|
1991-03-27 |
1995-06-20 |
Research Corporation Technologies, Inc. |
Methods of making single-stranded circular oligonucleotides
|
AU668349B2
(en)
|
1991-04-25 |
1996-05-02 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin 6 receptor
|
US5169766A
(en)
|
1991-06-14 |
1992-12-08 |
Life Technologies, Inc. |
Amplification of nucleic acid molecules
|
US5199441A
(en)
|
1991-08-20 |
1993-04-06 |
Hogle Hugh H |
Fine needle aspiration biopsy apparatus and method
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
US5298422A
(en)
|
1991-11-06 |
1994-03-29 |
Baylor College Of Medicine |
Myogenic vector systems
|
US5824307A
(en)
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
EP0625049A4
(fr)
|
1992-01-23 |
1995-07-12 |
Vical Inc |
Transfert de genes ex vivo.
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
JP3368603B2
(ja)
|
1992-02-28 |
2003-01-20 |
オリンパス光学工業株式会社 |
遺伝子治療用処置具
|
EP0563475B1
(fr)
|
1992-03-25 |
2000-05-31 |
Immunogen Inc |
Conjugués d'agents ciblés et de dérivés du CC-1065
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
US6132419A
(en)
|
1992-05-22 |
2000-10-17 |
Genetronics, Inc. |
Electroporetic gene and drug therapy
|
US5514545A
(en)
|
1992-06-11 |
1996-05-07 |
Trustees Of The University Of Pennsylvania |
Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
CA2141450A1
(fr)
|
1992-07-31 |
1994-02-17 |
Maureen Laney |
Methode d'introduction de sequences definies a l'extremite 3' des polynucleotides
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
AU5665694A
(en)
|
1992-11-04 |
1994-05-24 |
Denver Biomaterials Inc. |
Apparatus for removal of pleural effusion fluid
|
NZ258392A
(en)
|
1992-11-13 |
1997-09-22 |
Idec Pharma Corp |
Chimeric and radiolabelled antibodies to the b lymphocyte cellsurface antigen bp35 (cd-20) and their use in the treatment of b cell lymphona
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
DE69419721T2
(de)
|
1993-01-12 |
2000-04-27 |
Biogen Inc |
Rekombinante anti-vla4 antikörpermoleküle
|
FR2703253B1
(fr)
|
1993-03-30 |
1995-06-23 |
Centre Nat Rech Scient |
Applicateur d'impulsions electriques pour traitement de tissus biologiques.
|
US7135312B2
(en)
|
1993-04-15 |
2006-11-14 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
US5773244A
(en)
|
1993-05-19 |
1998-06-30 |
Regents Of The University Of California |
Methods of making circular RNA
|
US5851829A
(en)
|
1993-07-16 |
1998-12-22 |
Dana-Farber Cancer Institute |
Method of intracellular binding of target molecules
|
US5672491A
(en)
|
1993-09-20 |
1997-09-30 |
The Leland Stanford Junior University |
Recombinant production of novel polyketides
|
US6432711B1
(en)
|
1993-11-03 |
2002-08-13 |
Diacrin, Inc. |
Embryonic stem cells capable of differentiating into desired cell lines
|
US6096503A
(en)
|
1993-11-12 |
2000-08-01 |
The Scripps Research Institute |
Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
|
US7435802B2
(en)
|
1994-01-25 |
2008-10-14 |
Elan Pharaceuticals, Inc. |
Humanized anti-VLA4 immunoglobulins
|
US5840299A
(en)
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
ES2224113T5
(es)
|
1994-02-16 |
2009-05-01 |
The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Polipeptido antigenico asociado al melanoma, epitopos del mismo y vacunas contra melanoma.
|
IL112820A0
(en)
|
1994-03-07 |
1995-05-26 |
Merck & Co Inc |
Coordinate in vivo gene expression
|
WO1995024176A1
(fr)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Dispositif de remplissage d'ampoule
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
HUT76094A
(en)
|
1994-03-18 |
1997-06-30 |
Lynx Therapeutics |
Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
|
WO1995026204A1
(fr)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Stimulation immunitaire par des analogues d'oligonucleotides de phosphorothioate
|
US5457041A
(en)
|
1994-03-25 |
1995-10-10 |
Science Applications International Corporation |
Needle array and method of introducing biological substances into living cells using the needle array
|
US6074642A
(en)
|
1994-05-02 |
2000-06-13 |
Alexion Pharmaceuticals, Inc. |
Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
|
DE69535543T2
(de)
|
1994-05-18 |
2008-04-30 |
Bayer Bioscience Gmbh |
Für enzyme, die die fähigkeit besitzen lineare alpha 1,4-glucane in pflanzen, pilzen und mikroorganismen zu synthesieren, kodierende dna sequenzen
|
AU2656295A
(en)
|
1994-06-02 |
1996-01-04 |
Chiron Corporation |
Nucleic acid immunization using a virus-based infection/transfection system
|
GB9412230D0
(en)
|
1994-06-17 |
1994-08-10 |
Celltech Ltd |
Interleukin-5 specific recombiant antibodies
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
ATE306930T1
(de)
|
1994-08-12 |
2005-11-15 |
Immunomedics Inc |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
US5641665A
(en)
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
US5665545A
(en)
|
1994-11-28 |
1997-09-09 |
Akzo Nobel N.V. |
Terminal repeat amplification method
|
US5588960A
(en)
|
1994-12-01 |
1996-12-31 |
Vidamed, Inc. |
Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
JP3840259B2
(ja)
|
1995-01-06 |
2006-11-01 |
プラント リサーチ インターナショナル ベスローテン フェンノートシャップ |
炭水化物ポリマー合成酵素をコードするdna配列及びトランスジェニック植物を製造するための方法
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
US5824497A
(en)
*
|
1995-02-10 |
1998-10-20 |
Mcmaster University |
High efficiency translation of mRNA molecules
|
DE69629326D1
(de)
|
1995-02-15 |
2003-09-11 |
Joseph Eldor |
Spinalnadel mit mehreren Löchern
|
US5707807A
(en)
|
1995-03-28 |
1998-01-13 |
Research Development Corporation Of Japan |
Molecular indexing for expressed gene analysis
|
US5869230A
(en)
|
1995-03-30 |
1999-02-09 |
Beth Israel Hospital Association |
Gene transfer into the kidney
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
FR2733762B1
(fr)
|
1995-05-02 |
1997-08-01 |
Genset Sa |
Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
US6051429A
(en)
|
1995-06-07 |
2000-04-18 |
Life Technologies, Inc. |
Peptide-enhanced cationic lipid transfections
|
US6111095A
(en)
|
1995-06-07 |
2000-08-29 |
Merck & Co., Inc. |
Capped synthetic RNA, analogs, and aptamers
|
US5889136A
(en)
|
1995-06-09 |
1999-03-30 |
The Regents Of The University Of Colorado |
Orthoester protecting groups in RNA synthesis
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
WO1997011085A1
(fr)
|
1995-09-19 |
1997-03-27 |
University Of Massachusetts |
Inhibition de la degradation biologique d'oligodesoxynucleotides
|
US5830879A
(en)
|
1995-10-02 |
1998-11-03 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Treatment of vascular injury using vascular endothelial growth factor
|
US6265387B1
(en)
|
1995-10-11 |
2001-07-24 |
Mirus, Inc. |
Process of delivering naked DNA into a hepatocyte via bile duct
|
EP0771873A3
(fr)
|
1995-10-27 |
1998-03-04 |
Takeda Chemical Industries, Ltd. |
Protéine réceptrice neuronale à activité cellulaire
|
CU22584A1
(es)
|
1995-11-17 |
1999-11-03 |
Centro Inmunologia Molecular |
Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
US5962271A
(en)
|
1996-01-03 |
1999-10-05 |
Cloutech Laboratories, Inc. |
Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
WO1997030064A1
(fr)
|
1996-02-16 |
1997-08-21 |
Stichting Rega Vzw |
Oligonucleotides contenant de l'hexitol et leur utilisation dans des strategies antisens
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
US6090391A
(en)
|
1996-02-23 |
2000-07-18 |
Aviron |
Recombinant tryptophan mutants of influenza
|
SE9601245D0
(sv)
|
1996-03-29 |
1996-03-29 |
Pharmacia Ab |
Chimeric superantigens and their use
|
US6300487B1
(en)
|
1996-03-19 |
2001-10-09 |
Cell Therapuetics, Inc. |
Mammalian lysophosphatidic acid acyltransferase
|
TW517061B
(en)
|
1996-03-29 |
2003-01-11 |
Pharmacia & Amp Upjohn Ab |
Modified/chimeric superantigens and their use
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
US7329741B2
(en)
|
1996-06-05 |
2008-02-12 |
Chiron Corporation |
Polynucleotides that hybridize to DP-75 and their use
|
DE69739524D1
(de)
|
1996-06-05 |
2009-09-17 |
Novartis Vaccines & Diagnostic |
Dp-75 kodierende dna und verfahren zu ihrer verwendung
|
AU728422B2
(en)
|
1996-06-21 |
2001-01-11 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
JP2002515786A
(ja)
|
1996-06-28 |
2002-05-28 |
ソントラ メディカル,エル.ピー. |
経皮輸送の超音波増強
|
US5677124A
(en)
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
US5939262A
(en)
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
US5849546A
(en)
|
1996-09-13 |
1998-12-15 |
Epicentre Technologies Corporation |
Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
PT932678E
(pt)
|
1996-09-24 |
2006-07-31 |
Tanox Inc |
Familia de genes que codificam peptidos relacionados com apoptose, peptidos por eles codificados e metodos para sua utilizacao
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
ATE292980T1
(de)
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
EP0839912A1
(fr)
|
1996-10-30 |
1998-05-06 |
Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) |
Clones infectieux de virus à ARN, vaccins et essais diagnostiques
|
GB9623051D0
(en)
|
1996-11-06 |
1997-01-08 |
Schacht Etienne H |
Delivery of DNA to target cells in biological systems
|
US5980887A
(en)
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
US5759179A
(en)
|
1996-12-31 |
1998-06-02 |
Johnson & Johnson Medical, Inc. |
Needle and valve assembly for use with a catheter
|
RU2233878C2
(ru)
|
1997-01-21 |
2004-08-10 |
Дзе Дженерал Хоспитал Корпорейшн |
Способ отбора желательного белка и нуклеиновой кислоты, средства для его осуществления
|
EP0855184A1
(fr)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Composition pharmaceutique comprenant un polynucléotide et un antigène notamment pour la vaccination
|
IL131131A0
(en)
|
1997-02-07 |
2001-01-28 |
Merck & Co Inc |
Synthetic hiv gag genes
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
US5914269A
(en)
|
1997-04-04 |
1999-06-22 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of epidermal growth factor receptor expression
|
AU6972798A
(en)
|
1997-04-18 |
1998-11-13 |
University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
US5958688A
(en)
|
1997-04-28 |
1999-09-28 |
The Trustees Of The University Of Pennsylvania |
Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
US5989911A
(en)
|
1997-05-09 |
1999-11-23 |
University Of Massachusetts |
Site-specific synthesis of pseudouridine in RNA
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
US6124091A
(en)
|
1997-05-30 |
2000-09-26 |
Research Corporation Technologies, Inc. |
Cell growth-controlling oligonucleotides
|
CA2291483C
(fr)
|
1997-06-06 |
2012-09-18 |
Dynavax Technologies Corporation |
Oligonucleotides immunostimulateurs, compositions correspondantes et leurs procedes d'utilisation
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
DE69834038D1
(de)
|
1997-07-01 |
2006-05-18 |
Isis Pharmaceutical Inc |
Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
|
US5994511A
(en)
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
AU748097B2
(en)
|
1997-07-21 |
2002-05-30 |
Active Biotech Ab |
Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
|
CA2298811A1
(fr)
|
1997-07-31 |
1999-02-11 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Procede de traitement des greffons
|
US7151172B1
(en)
|
1997-09-18 |
2006-12-19 |
The Trustees Of The University Of Pennsylvania |
Attenuated vif DNA immunization cassettes for genetic vaccines
|
EP1021549A2
(fr)
|
1997-09-19 |
2000-07-26 |
Sequitur, Inc. |
THERAPIES GENIQUES A BASE D'ARNm SENS
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
EP1021548A1
(fr)
|
1997-10-07 |
2000-07-26 |
University Of Maryland Biotechnology Institute |
Procede d'introduction et d'expression d'arn dans des cellules animales
|
BR9812945A
(pt)
|
1997-10-20 |
2000-08-08 |
Genzyme Transgenics Corp |
Sequências de ácido nucléico modificadas e processos para aumentar os nìveis de mrna e expressão de sistemas celulares
|
US6019747A
(en)
|
1997-10-21 |
2000-02-01 |
I-Flow Corporation |
Spring-actuated infusion syringe
|
AU1275899A
(en)
|
1997-10-24 |
1999-05-17 |
Megabios Corporation |
Methods for preparing polynucleotide transfection complexes
|
EP1032428B1
(fr)
|
1997-11-20 |
2003-06-18 |
Vical Incorporated |
Traitement du cancer au moyen de polynucleotides exprimant la cytokine et compositions prevues a cet effet
|
US7655777B2
(en)
|
1997-11-24 |
2010-02-02 |
Monsanto Technology Llc |
Nucleic acid molecules associated with the tocopherol pathway
|
AU1819499A
(en)
|
1997-12-12 |
1999-06-28 |
Samyang Corporation |
Positively-charged poly{alpha-(omega-aminoalkyl)glycolic acid} for the delivery of a bioactive agent via tissue and cellular uptake
|
US6517869B1
(en)
|
1997-12-12 |
2003-02-11 |
Expression Genetics, Inc. |
Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
|
WO1999033982A2
(fr)
|
1997-12-23 |
1999-07-08 |
Chiron Corporation |
Genes humains et produits d'expression genique i
|
US6383811B2
(en)
|
1997-12-30 |
2002-05-07 |
Mirus Corporation |
Polyampholytes for delivering polyions to a cell
|
CA2317549C
(fr)
|
1998-01-05 |
2006-04-11 |
University Of Washington |
Composition pour l'amelioration du transport par l'utilisation de membranes contenant des lipides et utilisation connexe
|
AU740999B2
(en)
|
1998-01-08 |
2001-11-22 |
Sontra Medical, Inc. |
Sonophoretic enhanced transdermal transport
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
US8287483B2
(en)
|
1998-01-08 |
2012-10-16 |
Echo Therapeutics, Inc. |
Method and apparatus for enhancement of transdermal transport
|
US6365346B1
(en)
|
1998-02-18 |
2002-04-02 |
Dade Behring Inc. |
Quantitative determination of nucleic acid amplification products
|
US5955310A
(en)
|
1998-02-26 |
1999-09-21 |
Novo Nordisk Biotech, Inc. |
Methods for producing a polypeptide in a bacillus cell
|
US6432925B1
(en)
|
1998-04-16 |
2002-08-13 |
John Wayne Cancer Institute |
RNA cancer vaccine and methods for its use
|
US6429301B1
(en)
|
1998-04-17 |
2002-08-06 |
Whitehead Institute For Biomedical Research |
Use of a ribozyme to join nucleic acids and peptides
|
GB9808327D0
(en)
|
1998-04-20 |
1998-06-17 |
Chiron Spa |
Antidiotypic compounds
|
EP2116600B1
(fr)
|
1998-04-23 |
2013-09-18 |
Takara Bio Inc. |
Méthode de synthèse d'ADN
|
US6395253B2
(en)
|
1998-04-23 |
2002-05-28 |
The Regents Of The University Of Michigan |
Microspheres containing condensed polyanionic bioactive agents and methods for their production
|
US20020064517A1
(en)
|
1998-04-30 |
2002-05-30 |
Stewart A. Cederholm-Williams |
Fibrin sealant as a transfection/transformation vehicle for gene therapy
|
US20090208418A1
(en)
|
2005-04-29 |
2009-08-20 |
Innexus Biotechnology Internaltional Ltd. |
Superantibody synthesis and use in detection, prevention and treatment of disease
|
BR9911062A
(pt)
|
1998-05-20 |
2001-02-06 |
Expression Genetics Inc |
Veìculo de gene polimérico de poli-l-lisina enxertado por polietileno glicol de direcionamento de hepatócito
|
US6503231B1
(en)
|
1998-06-10 |
2003-01-07 |
Georgia Tech Research Corporation |
Microneedle device for transport of molecules across tissue
|
US7091192B1
(en)
|
1998-07-01 |
2006-08-15 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
JP2002520435A
(ja)
|
1998-07-13 |
2002-07-09 |
エクスプレション・ジェネティックス・インコーポレーテッド |
可溶性、生物分解性な遺伝子輸送キャリアーとしてのポリ−l−リジンのポリエステル類似体
|
JP2003505114A
(ja)
|
1998-07-13 |
2003-02-12 |
ジェネトロニクス、インコーポレーテッド |
パルス電場による皮膚および筋肉を標的とした遺伝子治療
|
US6222030B1
(en)
|
1998-08-03 |
2001-04-24 |
Agilent Technologies, Inc. |
Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
|
EA004107B1
(ru)
|
1998-08-11 |
2003-12-25 |
Айдек Фармацевтикалс Корпорэйшн |
Комбинированная терапия в-клеточных лимфом, предусматривающая введение антитела против cd20
|
GB9817662D0
(en)
|
1998-08-13 |
1998-10-07 |
Crocker Peter J |
Substance delivery
|
US6924365B1
(en)
|
1998-09-29 |
2005-08-02 |
Transkaryotic Therapies, Inc. |
Optimized messenger RNA
|
US20090042283A1
(en)
|
1998-09-29 |
2009-02-12 |
Shire Human Genetic Therapies, Inc., A Delaware Corporation |
Optimized messenger rna
|
WO2000026226A1
(fr)
|
1998-11-03 |
2000-05-11 |
Yale University |
Detecteurs moleculaires polynucleotidiques a domaines multiples
|
MY155913A
(en)
|
1998-11-09 |
2015-12-15 |
Biogen Inc |
Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transpants
|
WO2000027428A1
(fr)
|
1998-11-09 |
2000-05-18 |
Idec Pharmaceuticals Corporation |
Traitement d'affections malignes hematologiques associees a des cellules tumorales en circulation au moyen d'un anticorps chimere anti-cd 20
|
AU2023400A
(en)
|
1998-11-12 |
2000-05-29 |
Children's Medical Center Corporation |
Compositions and methods for inhibiting angiogenesis using trna and fragments thereof
|
US6210931B1
(en)
|
1998-11-30 |
2001-04-03 |
The United States Of America As Represented By The Secretary Of Agriculture |
Ribozyme-mediated synthesis of circular RNA
|
US20040171980A1
(en)
|
1998-12-18 |
2004-09-02 |
Sontra Medical, Inc. |
Method and apparatus for enhancement of transdermal transport
|
JP2002533134A
(ja)
|
1998-12-23 |
2002-10-08 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
ペプチドグリカン認識タンパク質
|
WO2000050586A2
(fr)
|
1999-02-22 |
2000-08-31 |
European Molecular Biology Laboratory |
Systeme de traduction in vitro
|
US6255476B1
(en)
|
1999-02-22 |
2001-07-03 |
Pe Corporation (Ny) |
Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
|
US7629311B2
(en)
|
1999-02-24 |
2009-12-08 |
Edward Lewis Tobinick |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
|
CA2689696C
(fr)
|
1999-02-26 |
2013-08-06 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions a macromolecules et microparticules adsorbees
|
AU778809B2
(en)
|
1999-03-29 |
2004-12-23 |
Statens Serum Institut |
Method for producing a nucleotide sequence construct with optimised codons for an HIV genetic vaccine based on primary, early HIV isolate and synthetic envelope BX08 constructs
|
EP1177231B1
(fr)
|
1999-04-09 |
2009-08-19 |
Invitrogen Dynal AS |
Procede pour preparer des particules polymeres monodispersees
|
DK1176981T3
(da)
|
1999-05-07 |
2006-04-10 |
Genentech Inc |
Behandling af autoimmune sygdomme med antagonister som binder til B celleoverflademarkörer
|
KR20020011985A
(ko)
|
1999-05-07 |
2002-02-09 |
파르마솔 게엠베하 |
액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
WO2000075356A1
(fr)
|
1999-06-04 |
2000-12-14 |
Lin Shi Lung |
Amplification en chaine d'arn par polymerase
|
US6743211B1
(en)
|
1999-11-23 |
2004-06-01 |
Georgia Tech Research Corporation |
Devices and methods for enhanced microneedle penetration of biological barriers
|
US6611707B1
(en)
|
1999-06-04 |
2003-08-26 |
Georgia Tech Research Corporation |
Microneedle drug delivery device
|
US6303573B1
(en)
|
1999-06-07 |
2001-10-16 |
The Burnham Institute |
Heart homing peptides and methods of using same
|
CA2376634A1
(fr)
|
1999-06-08 |
2000-12-14 |
Aventis Pasteur |
Oligonucleotide immunostimulant
|
EP1194167B1
(fr)
|
1999-06-09 |
2009-08-19 |
Immunomedics, Inc. |
Immunotherapie de troubles auto-immuns a l'aide d'anticorps ciblant les cellules b
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
IL147179A0
(en)
|
1999-06-30 |
2002-08-14 |
Advanced Cell Tech Inc |
Cytoplasmic transfer to de-differentiate recipient cells
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
CA2378653A1
(fr)
|
1999-07-09 |
2001-01-18 |
American Home Products Corporation |
Methodes et compositions empechant la formation d'un arn aberrant pendant la transcription d'une sequence plasmidique
|
US8557244B1
(en)
|
1999-08-11 |
2013-10-15 |
Biogen Idec Inc. |
Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
|
EP1792991A1
(fr)
|
1999-08-24 |
2007-06-06 |
Medarex, Inc. |
Anticorps humains contre CTLA-4 et leur utilisation
|
US20050112141A1
(en)
|
2000-08-30 |
2005-05-26 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
US20040106567A1
(en)
|
1999-09-07 |
2004-06-03 |
Hagstrom James E. |
Intravascular delivery of non-viral nucleic acid
|
DE69923840T2
(de)
|
1999-09-09 |
2006-04-06 |
Curevac Gmbh |
Transfer von mRNAs unter Verwendung von polykationischen Verbindungen
|
AU7398200A
(en)
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US6623457B1
(en)
|
1999-09-22 |
2003-09-23 |
Becton, Dickinson And Company |
Method and apparatus for the transdermal administration of a substance
|
WO2002064799A2
(fr)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Arn messager optimise
|
AU7863200A
(en)
|
1999-10-06 |
2001-05-10 |
Quark Biotech, Inc. |
Method for enrichment of natural antisense messenger rna
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
US6613026B1
(en)
|
1999-12-08 |
2003-09-02 |
Scimed Life Systems, Inc. |
Lateral needle-less injection apparatus and method
|
US6277974B1
(en)
|
1999-12-14 |
2001-08-21 |
Cogent Neuroscience, Inc. |
Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
|
US6245929B1
(en)
|
1999-12-20 |
2001-06-12 |
General Electric Company |
Catalyst composition and method for producing diaryl carbonates, using bisphosphines
|
ATE280188T1
(de)
|
1999-12-22 |
2004-11-15 |
Basell Poliolefine Spa |
Alpha-olefin enthaltendes polymerisationskatalysatorsystem, das ein aromatisches silan enthält
|
US7737108B1
(en)
|
2000-01-07 |
2010-06-15 |
University Of Washington |
Enhanced transport using membrane disruptive agents
|
WO2001051661A2
(fr)
|
2000-01-13 |
2001-07-19 |
Amsterdam Support Diagnostics B.V. |
Systeme universel d'amplification de l'acide nucleique pour acides nucleiques d'un prelevement
|
EP1253947A4
(fr)
|
2000-01-31 |
2005-01-05 |
Univ California |
Polynucleotides immunomodulateurs dans le traitement d'une infection par un pathogene intracellulaire
|
CA2395811A1
(fr)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Acides nucleiques, proteines, et anticorps
|
WO2001062827A2
(fr)
|
2000-02-22 |
2001-08-30 |
Shearwater Corporation |
Derives de polymere n-maleimidyle
|
DK1481992T3
(en)
|
2000-02-24 |
2017-01-30 |
Washington Univ St Louis |
Humanized antibodies which sequester amyloid beta peptide
|
CA2401327C
(fr)
|
2000-03-03 |
2014-05-06 |
Valentis, Inc. |
Formulations d'acide nucleique comportant des polyaminoacides pour la delivrance de genes et procedes d'utilisation
|
US20020081597A1
(en)
|
2000-03-31 |
2002-06-27 |
Genentech, Inc. |
Compositions and methods for detecting and quantifying gene expression
|
CA2404365A1
(fr)
|
2000-03-31 |
2001-10-11 |
Idec Pharmaceutical Corporation |
Utilisation combinee d'anticorps ou d'antagonistes anti-cytokine et d'anti-cd20 pour le traitement du lymphome b
|
US6565572B2
(en)
|
2000-04-10 |
2003-05-20 |
Sdgi Holdings, Inc. |
Fenestrated surgical screw and method
|
US6368801B1
(en)
|
2000-04-12 |
2002-04-09 |
Molecular Staging, Inc. |
Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase
|
AU2001259063A1
(en)
|
2000-04-12 |
2001-10-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20010046496A1
(en)
|
2000-04-14 |
2001-11-29 |
Brettman Lee R. |
Method of administering an antibody
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US20040229271A1
(en)
|
2000-05-19 |
2004-11-18 |
Williams Richard B. |
Compositions and methods for the identification and selection of nucleic acids and polypeptides
|
WO2001092523A2
(fr)
|
2000-05-30 |
2001-12-06 |
Curagen Corporation |
Nouveaux polynucleotides humains et polypeptides codes par ceux-ci
|
CA2412026A1
(fr)
|
2000-06-07 |
2001-12-13 |
Biosynexus Incorporated |
Molecules hybrides arn/adn immunostimulatrices
|
CN1298738C
(zh)
|
2000-06-23 |
2007-02-07 |
惠氏控股有限公司 |
修饰的麻疹病毒v蛋白
|
AU2001276619A1
(en)
|
2000-07-03 |
2002-01-14 |
Chiron S.P.A. |
Immunisation against chlamydia pneumoniae
|
US6440096B1
(en)
|
2000-07-14 |
2002-08-27 |
Becton, Dickinson And Co. |
Microdevice and method of manufacturing a microdevice
|
DK1301614T3
(da)
|
2000-07-21 |
2007-04-02 |
Glaxo Group Ltd |
Codon-optimerede papillomavirus-sekvenser
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
US20040142474A1
(en)
|
2000-09-14 |
2004-07-22 |
Expression Genetics, Inc. |
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
WO2002024873A1
(fr)
|
2000-09-20 |
2002-03-28 |
Christopher Ralph Franks |
Therapie a base de cellules souches
|
JP2004510714A
(ja)
|
2000-10-04 |
2004-04-08 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア |
フラビウイルス及びペスチウイルス由来のキャプシド蛋白質を使用する組成物及び方法
|
US6998115B2
(en)
|
2000-10-10 |
2006-02-14 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
US7202226B2
(en)
|
2000-10-23 |
2007-04-10 |
Detroit R & D |
Augmentation of wound healing by elF-4E mRNA and EGF mRNA
|
US20030077604A1
(en)
|
2000-10-27 |
2003-04-24 |
Yongming Sun |
Compositions and methods relating to breast specific genes and proteins
|
US20020132788A1
(en)
|
2000-11-06 |
2002-09-19 |
David Lewis |
Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
|
WO2002040545A2
(fr)
|
2000-11-17 |
2002-05-23 |
The Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services |
Reduction de la toxicite animale non specifique des immunotoxines par mutation des regions d'infrastructure de fv pour reduire le point isoelectrique
|
JP2004535765A
(ja)
|
2000-12-07 |
2004-12-02 |
カイロン コーポレイション |
前立腺癌においてアップレギュレートされた内因性レトロウイルス
|
US7708915B2
(en)
|
2004-05-06 |
2010-05-04 |
Castor Trevor P |
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
|
US20020130430A1
(en)
|
2000-12-29 |
2002-09-19 |
Castor Trevor Percival |
Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products
|
EP1224943A1
(fr)
|
2001-01-19 |
2002-07-24 |
Crucell Holland B.V. |
Fibronectin comme marqueur de tumeurs, détectée par des anticorps exprimés sur phages
|
CN101921732A
(zh)
|
2001-01-19 |
2010-12-22 |
维洛诺瓦蒂夫公司 |
在易感哺乳动物中引起呼吸道疾病的病毒
|
US20040110191A1
(en)
|
2001-01-31 |
2004-06-10 |
Winkler Matthew M. |
Comparative analysis of nucleic acids using population tagging
|
WO2002065093A2
(fr)
|
2001-02-14 |
2002-08-22 |
Baylor College Of Medicine |
Procedes et compositions d'amplification d'arn
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
US7232425B2
(en)
|
2001-03-02 |
2007-06-19 |
Sorenson Development, Inc. |
Apparatus and method for specific interstitial or subcutaneous diffusion and dispersion of medication
|
KR100917939B1
(ko)
|
2001-03-09 |
2009-09-21 |
진 스트림 피티와이 리미티드 |
신규한 발현 벡터
|
JP2002262882A
(ja)
|
2001-03-12 |
2002-09-17 |
Nisshinbo Ind Inc |
Rnaの増幅法
|
FR2822164B1
(fr)
|
2001-03-19 |
2004-06-18 |
Centre Nat Rech Scient |
Polypeptides derives des arn polymerases, et leurs utilisations
|
US6520949B2
(en)
|
2001-04-02 |
2003-02-18 |
Martin St. Germain |
Method and apparatus for administering fluid to animals subcutaneously
|
DE10119005A1
(de)
|
2001-04-18 |
2002-10-24 |
Roche Diagnostics Gmbh |
Verfahren zur Proteinexpression ausgehend von stabilisierter linearer kurzer DNA in zellfreien in vitro-Transkription/Translations-Systemen mit Exonuklease-haltigen Lysaten oder in einem zellulären System enthaltend Exonukleasen
|
US20030171253A1
(en)
|
2001-04-19 |
2003-09-11 |
Averil Ma |
Methods and compositions relating to modulation of A20
|
DE50201240D1
(de)
|
2001-04-23 |
2004-11-11 |
Amaxa Gmbh |
Pufferlössung für die elektroporation und verfahren umfassend die verwendung derselben
|
US7560424B2
(en)
|
2001-04-30 |
2009-07-14 |
Zystor Therapeutics, Inc. |
Targeted therapeutic proteins
|
US6777187B2
(en)
|
2001-05-02 |
2004-08-17 |
Rubicon Genomics, Inc. |
Genome walking by selective amplification of nick-translate DNA library and amplification from complex mixtures of templates
|
US6527216B2
(en)
|
2001-05-08 |
2003-03-04 |
Magnatech International Llp |
Electronic length control wire pay-off system and method
|
US20050137155A1
(en)
|
2001-05-18 |
2005-06-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated treatment of Parkinson disease using short interfering nucleic acid (siNA)
|
US8137911B2
(en)
|
2001-05-22 |
2012-03-20 |
Cellscript, Inc. |
Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
|
EP1404860B8
(fr)
|
2001-05-30 |
2013-12-25 |
The Scripps Research Institute |
Systeme de delivrance d'acides nucleiques
|
DE50214200D1
(de)
|
2001-06-05 |
2010-03-25 |
Curevac Gmbh |
Stabilisierte Tumorantigen-mRNA mit erhöhtem G/C-Gehalt
|
JP2005503135A
(ja)
|
2001-06-18 |
2005-02-03 |
ノバルティス アクチエンゲゼルシャフト |
新規gタンパク質共役受容体およびそのdna配列
|
US7547551B2
(en)
|
2001-06-21 |
2009-06-16 |
University Of Antwerp. |
Transfection of eukaryontic cells with linear polynucleotides by electroporation
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
EP1404716A2
(fr)
|
2001-06-26 |
2004-04-07 |
Novartis AG |
Nouveaux recepteurs couples a la proteine g et leurs sequences d'adn
|
SE0102327D0
(sv)
|
2001-06-28 |
2001-06-28 |
Active Biotech Ab |
A novel engineered superantigen for human therapy
|
US20040236092A1
(en)
|
2001-07-13 |
2004-11-25 |
Roman Dziarski |
Peptidologlycan recognition protein encoding nucleic acids and methods of use thereof
|
US6586524B2
(en)
|
2001-07-19 |
2003-07-01 |
Expression Genetics, Inc. |
Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
|
US7169750B2
(en)
|
2001-07-31 |
2007-01-30 |
Anormed, Inc. |
Methods to mobilize progenitor/stem cells
|
AU2002312543A1
(en)
|
2001-08-01 |
2003-02-17 |
University Of Utah, Technology Transfer Office |
Isoform-selective inhibitors and activators of pde3 cyclic
|
EP1423519A2
(fr)
|
2001-08-27 |
2004-06-02 |
Novartis AG |
Recepteur couple aux proteines g nouvellement identifie et sequences d'adn de ce recepteur
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
DE10148886A1
(de)
|
2001-10-04 |
2003-04-30 |
Avontec Gmbh |
Inhibition von STAT-1
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
WO2003042383A1
(fr)
|
2001-11-14 |
2003-05-22 |
Toyo Boseki Kabushiki Kaisha |
Promoteurs de replication de l'adn, facteurs associes a l'adn polymerase et utilisation de ces derniers
|
WO2003044482A2
(fr)
|
2001-11-16 |
2003-05-30 |
The University Of Tennessee Research Corporation |
Proteines de fusion d'anticorps de recombinaison et procedes de detection de cellules apoptotiques
|
WO2003046578A2
(fr)
|
2001-11-29 |
2003-06-05 |
Novartis Ag |
Méthode pour estimer et faire un pronostic sur la sarcoidose
|
CA2409775C
(fr)
|
2001-12-03 |
2010-07-13 |
F. Hoffmann-La Roche Ag |
Enzymes thermostables modifies de facon reversible pour la synthese de l'adn et l'amplification in vitro
|
JP4646315B2
(ja)
|
2001-12-07 |
2011-03-09 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
前立腺癌においてアップレギュレートされた内因性レトロウイルス
|
US20060275747A1
(en)
|
2001-12-07 |
2006-12-07 |
Hardy Stephen F |
Endogenous retrovirus up-regulated in prostate cancer
|
EP1521594B1
(fr)
|
2001-12-07 |
2013-10-02 |
Novartis Vaccines and Diagnostics, Inc. |
Polypeptides de retrovirus endogenes lies a la transformation oncogenique
|
JP2005520498A
(ja)
|
2001-12-17 |
2005-07-14 |
ノバルティス アクチエンゲゼルシャフト |
新規gタンパク質共役受容体およびそのdna配列
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
PT1474109E
(pt)
|
2001-12-21 |
2010-10-25 |
Alcon Inc |
Utilização de nanopartículas inorgânicas sintéticas como veículos em medicamentos oftálmicos
|
WO2003059381A2
(fr)
|
2002-01-18 |
2003-07-24 |
Curevac Gmbh |
Préparations immunogènes et vaccins à base d'arn
|
WO2003066649A1
(fr)
|
2002-02-04 |
2003-08-14 |
Biomira Inc. |
Lipido-oligonucleotides covalents et immunostimulants
|
EP2048154B2
(fr)
|
2002-02-05 |
2015-06-03 |
Genentech, Inc. |
Purification de protéine
|
FR2835749B1
(fr)
|
2002-02-08 |
2006-04-14 |
Inst Nat Sante Rech Med |
Composition pharmaceutique ameliorant le transfert de gene in vivo
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
US7354742B2
(en)
|
2002-02-22 |
2008-04-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for generating amplified RNA
|
EP1572941A4
(fr)
|
2002-02-26 |
2009-03-18 |
Maxygen Inc |
Nouveaux antigenes de flavivirus
|
EP1916001B1
(fr)
|
2002-03-04 |
2011-05-25 |
Imclone LLC |
Anticorps humains spécifiques pour le KDR et leurs utilisations
|
AU2003221497A1
(en)
|
2002-03-13 |
2003-09-22 |
Novartis Ag |
Pharmaceutical microparticles
|
US7074596B2
(en)
|
2002-03-25 |
2006-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse mRNA cap analogues
|
EP2368431A1
(fr)
|
2002-04-04 |
2011-09-28 |
Coley Pharmaceutical GmbH |
Oligoribonucléotides contenant G,U immunostimulatrices
|
WO2003087815A2
(fr)
|
2002-04-17 |
2003-10-23 |
Novartis Ag |
Criblage de composes
|
GB0209539D0
(en)
|
2002-04-26 |
2002-06-05 |
Avecia Ltd |
Monomer Polymer and process
|
EP1361277A1
(fr)
|
2002-04-30 |
2003-11-12 |
Centre National De La Recherche Scientifique (Cnrs) |
Optimisation d'expression transgenique dans des cellules mammaliennes
|
EP1507556B1
(fr)
|
2002-05-02 |
2016-07-27 |
Wyeth Holdings LLC |
Conjugues de type vecteur-derive de calicheamicine
|
US7374930B2
(en)
|
2002-05-21 |
2008-05-20 |
Expression Genetics, Inc. |
GLP-1 gene delivery for the treatment of type 2 diabetes
|
US20040018525A1
(en)
|
2002-05-21 |
2004-01-29 |
Bayer Aktiengesellschaft |
Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma
|
DE10224200C1
(de)
|
2002-05-31 |
2003-08-21 |
Artus Ges Fuer Molekularbiolog |
Vermehrung von Ribonukleinsäuren
|
AU2003237367A1
(en)
|
2002-06-03 |
2003-12-19 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
US7901708B2
(en)
|
2002-06-28 |
2011-03-08 |
Protiva Biotherapeutics, Inc. |
Liposomal apparatus and manufacturing methods
|
NZ537306A
(en)
|
2002-07-01 |
2008-11-28 |
Kenneth S Warren Inst Inc |
Compositions comprising mutein recombinant tissue protective cytokines having one or more amino acid substitutions facilitating transport of a molecule via transcytosis across an endothelial cell barrier
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
GB0215509D0
(en)
|
2002-07-04 |
2002-08-14 |
Novartis Ag |
Marker genes
|
US7316925B2
(en)
|
2002-07-16 |
2008-01-08 |
Vgx Pharmaceuticals, Inc. |
Codon optimized synthetic plasmids
|
US7927791B2
(en)
|
2002-07-24 |
2011-04-19 |
Ptc Therapeutics, Inc. |
Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mRNA decay
|
EP1393745A1
(fr)
|
2002-07-29 |
2004-03-03 |
Hybridon, Inc. |
Modulation des proprietes immunostimulatrices de composes a base d'oligonucleotides par presentation optimale des extremites 5'
|
EP1386925A1
(fr)
|
2002-07-31 |
2004-02-04 |
Girindus AG |
Procédé de préparation des oligonucleotides
|
US6653468B1
(en)
|
2002-07-31 |
2003-11-25 |
Isis Pharmaceuticals, Inc. |
Universal support media for synthesis of oligomeric compounds
|
EP1873180B1
(fr)
|
2002-08-14 |
2014-05-07 |
Novartis AG |
Dispositif ophtalmique fabriqué à partir d'un prépolymère durcissable par radiation
|
MX367615B
(es)
|
2002-09-06 |
2019-08-28 |
Cerulean Pharma Inc |
Polimeros a base de ciclodextrina para el suministro de agentes terapeuticos.
|
US7569214B2
(en)
|
2002-09-09 |
2009-08-04 |
Nektar Therapeutics Al, Corporation |
Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
|
US7534872B2
(en)
|
2002-09-27 |
2009-05-19 |
Syngen, Inc. |
Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis
|
EP3284753B1
(fr)
|
2002-10-17 |
2019-06-05 |
Genmab A/S |
Anticorps monoclonaux humains contre le cd20 pour le traitement de la sclérose en plaques
|
CN100572535C
(zh)
|
2002-10-22 |
2009-12-23 |
卫材R&D管理有限公司 |
在分裂停止后的产多巴胺型神经元前体细胞中特异性表达的基因
|
CA2506805A1
(fr)
|
2002-11-21 |
2004-06-10 |
Epicentre Technologies Corporation |
Procedes d'utilisation d'amorces qui codent un brin d'un promoteur bicatenaire
|
US7491234B2
(en)
|
2002-12-03 |
2009-02-17 |
Boston Scientific Scimed, Inc. |
Medical devices for delivery of therapeutic agents
|
TWI335821B
(en)
|
2002-12-16 |
2011-01-11 |
Genentech Inc |
Immunoglobulin variants and uses thereof
|
JP2006516099A
(ja)
|
2002-12-23 |
2006-06-22 |
ダイナバックス テクノロジーズ コーポレイション |
分枝状の免疫調節化合物及び該化合物の使用方法
|
US7169892B2
(en)
|
2003-01-10 |
2007-01-30 |
Astellas Pharma Inc. |
Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
|
WO2004067728A2
(fr)
|
2003-01-17 |
2004-08-12 |
Ptc Therapeutics |
Procedes et systemes pour identifier des sequences regulatrices d'arn et des composes modulant leur fonction
|
US9068234B2
(en)
|
2003-01-21 |
2015-06-30 |
Ptc Therapeutics, Inc. |
Methods and agents for screening for compounds capable of modulating gene expression
|
US8426194B2
(en)
|
2003-01-21 |
2013-04-23 |
Ptc Therapeutics, Inc. |
Methods and agents for screening for compounds capable of modulating VEGF expression
|
CA2514184C
(fr)
|
2003-01-21 |
2016-04-12 |
Ptc Therapeutics, Inc. |
Procedes pour identifier des composes qui modulent l'expression de genes dependants d'une region non traduite, et procedes d'utilisation correspondants
|
US20040147027A1
(en)
|
2003-01-28 |
2004-07-29 |
Troy Carol M. |
Complex for facilitating delivery of dsRNA into a cell and uses thereof
|
JP4728948B2
(ja)
|
2003-02-10 |
2011-07-20 |
エラン ファーマシューティカルズ,インコーポレイテッド |
免疫グロブリン製剤およびその調製の方法
|
US20040167090A1
(en)
|
2003-02-21 |
2004-08-26 |
Monahan Sean D. |
Covalent modification of RNA for in vitro and in vivo delivery
|
CA2450289A1
(fr)
|
2003-03-20 |
2005-05-19 |
Imclone Systems Incorporated |
Methode de production d'un anticorps ciblant le recepteur du facteur de croissance epidermique
|
US7320961B2
(en)
|
2003-03-24 |
2008-01-22 |
Abbott Laboratories |
Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
|
AU2004225520A1
(en)
|
2003-03-25 |
2004-10-14 |
Stratagene |
DNA polymerase fusions and uses thereof
|
US20040242502A1
(en)
|
2003-04-08 |
2004-12-02 |
Galenica Pharmaceuticals, Inc. |
Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines
|
SI1613350T1
(sl)
|
2003-04-09 |
2009-08-31 |
Genentech Inc |
Zdravljenje avtoimunske bolezni pri bolniku z neustreznim odzivom na inhibitor TNF-alfa
|
ES2440654T3
(es)
|
2003-05-05 |
2014-01-29 |
Ben-Gurion University Of The Negev Research And Development Authority |
Preparaciones poliméricas reticuladas inyectables y usos de las mismas
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
EP2298347B1
(fr)
|
2003-05-06 |
2015-09-30 |
Biogen Hemophilia Inc. |
Protéines chimériques du facteur de la coagulation pour le traitement d'un trouble de l'hémostase
|
US9567591B2
(en)
|
2003-05-15 |
2017-02-14 |
Mello Biotechnology, Inc. |
Generation of human embryonic stem-like cells using intronic RNA
|
GB0313132D0
(en)
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
EP1636385A4
(fr)
|
2003-06-24 |
2010-06-02 |
Mirus Bio Corp |
Inhibition d'une fonction genique par distribution in vivo d'inhibiteurs d'expression genique a base de polynucleotides dans des cellules mammiferes
|
GB0316089D0
(en)
|
2003-07-09 |
2003-08-13 |
Xo Bioscience Ltd |
Differentiation method
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
US7575572B2
(en)
|
2003-07-15 |
2009-08-18 |
Spinal Generations, Llc |
Method and device for delivering medicine to bone
|
US20050013870A1
(en)
|
2003-07-17 |
2005-01-20 |
Toby Freyman |
Decellularized extracellular matrix of conditioned body tissues and uses thereof
|
CN103880955A
(zh)
|
2003-07-18 |
2014-06-25 |
安姆根有限公司 |
肝细胞生长因子的特异性结合物
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
US8668926B1
(en)
|
2003-09-15 |
2014-03-11 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
US7135010B2
(en)
|
2003-09-30 |
2006-11-14 |
Damage Control Surgical Technologies, Inc. |
Method and apparatus for rapid deployment chest drainage
|
EP1673473B1
(fr)
|
2003-10-06 |
2011-07-06 |
Novartis AG |
Utilisation de polymorphismes genetiques compatibles avec l'efficacite de traitement des maladies inflammatoires
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
US20050130201A1
(en)
|
2003-10-14 |
2005-06-16 |
Dharmacon, Inc. |
Splint-assisted enzymatic synthesis of polyribounucleotides
|
WO2005044859A2
(fr)
|
2003-11-05 |
2005-05-19 |
Glycart Biotechnology Ag |
Molecules fixatrices d'antigenes presentant une affinite de fixation du recepteur de fc et une fonction effectrice accrues
|
WO2005047536A2
(fr)
|
2003-11-13 |
2005-05-26 |
Novartis Ag |
Detection d'amplification et de deletion genomiques dans le cancer
|
US20070054278A1
(en)
|
2003-11-18 |
2007-03-08 |
Applera Corporation |
Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
|
US7699852B2
(en)
|
2003-11-19 |
2010-04-20 |
Zimmer Spine, Inc. |
Fenestrated bone tap and method
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
US8529939B2
(en)
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US7674884B2
(en)
|
2003-12-10 |
2010-03-09 |
Novimmune S.A. |
Neutralizing antibodies and methods of use thereof
|
US8372966B2
(en)
|
2003-12-19 |
2013-02-12 |
University Of Cincinnati |
Oligonucleotide decoys and methods of use
|
EP1703893B1
(fr)
|
2003-12-23 |
2012-04-11 |
Genentech, Inc. |
Nouveaux anticorps anti-il 13 et utilisations associees
|
EP1713514B1
(fr)
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Medicaments et particules de transport de genes se depla ant rapidement a travers les barrieres muqueuses
|
US20070224635A1
(en)
|
2004-01-30 |
2007-09-27 |
Maxygen Holdings, Ltd. |
Regulated Stop Codon Readthrough
|
US7309487B2
(en)
|
2004-02-09 |
2007-12-18 |
George Inana |
Methods and compositions for detecting and treating retinal diseases
|
JP4805848B2
(ja)
|
2004-02-12 |
2011-11-02 |
モルフォテック、インク. |
腫瘍抗原の生物活性を特異的に阻止するモノクローナル抗体
|
US20070265220A1
(en)
|
2004-03-15 |
2007-11-15 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
EP3736295A1
(fr)
|
2004-03-24 |
2020-11-11 |
Chugai Seiyaku Kabushiki Kaisha |
Sous-types d'anticorps humanisés contre le récepteur de l'interleukine-6
|
WO2005098433A2
(fr)
|
2004-04-01 |
2005-10-20 |
Novartis Ag |
Methodes diagnostiques de la maladie d'alzheimer
|
WO2005103081A2
(fr)
|
2004-04-20 |
2005-11-03 |
Genmab A/S |
Anticorps monoclonaux humains diriges contre cd20
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
US20080119645A1
(en)
|
2004-05-05 |
2008-05-22 |
Isis Pharmaceuticals, Inc. |
Amidites and Methods of Rna Synthesis
|
MXPA06012990A
(es)
|
2004-05-12 |
2007-02-12 |
Baxter Int |
Microesferas de acidos nucleicos, produccion y suministro de las mismas.
|
WO2005117557A2
(fr)
|
2004-06-01 |
2005-12-15 |
San Diego State University Foundation |
Systeme d'expression
|
AU2005252273B2
(en)
|
2004-06-07 |
2011-04-28 |
Arbutus Biopharma Corporation |
Lipid encapsulated interfering RNA
|
AU2005251403B2
(en)
|
2004-06-07 |
2011-09-01 |
Arbutus Biopharma Corporation |
Cationic lipids and methods of use
|
CA2608862C
(fr)
|
2004-06-11 |
2020-05-05 |
Trustees Of Tufts College |
Systeme d'administration de medicament a base de soie
|
WO2006046978A2
(fr)
|
2004-06-28 |
2006-05-04 |
Argos Therapeutics, Inc. |
Transformation par l'intermediaire de peptides cationiques
|
WO2006005058A2
(fr)
|
2004-06-30 |
2006-01-12 |
Nektar Therapeutics Al, Corporation |
Conjugues polymere-fraction facteur ix
|
AU2005328382C1
(en)
|
2004-07-21 |
2013-01-24 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
DE102004035227A1
(de)
|
2004-07-21 |
2006-02-16 |
Curevac Gmbh |
mRNA-Gemisch zur Vakzinierung gegen Tumorerkrankungen
|
US7603349B1
(en)
|
2004-07-29 |
2009-10-13 |
Yahoo! Inc. |
User interfaces for search systems using in-line contextual queries
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
US7291208B2
(en)
|
2004-08-13 |
2007-11-06 |
Gore Enterprise Holdings, Inc. |
Grooved active and passive adsorbent filters
|
SE0402025D0
(sv)
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
CA2478458A1
(fr)
|
2004-08-20 |
2006-02-20 |
Michael Panzara |
Traitement de la sclerose en plaques pediatrique
|
NZ553910A
(en)
|
2004-08-26 |
2009-05-31 |
Engeneic Molecular Delivery Pty |
Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
US7501486B2
(en)
|
2004-09-07 |
2009-03-10 |
Burnham Institute For Medical Research |
Peptides that selectively home to heart vasculature and related conjugates and methods
|
US8663599B1
(en)
|
2004-10-05 |
2014-03-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
JPWO2006041088A1
(ja)
|
2004-10-12 |
2008-05-15 |
株式会社ティッシュターゲティングジャパン |
脳移行性骨髄前駆細胞
|
EP1799659A1
(fr)
|
2004-10-13 |
2007-06-27 |
PTC Therapeutics, Inc. |
Composés permettant de supprimer les effets des mutations non-sens, et méthodes d emploi desdits composés
|
US8057821B2
(en)
|
2004-11-03 |
2011-11-15 |
Egen, Inc. |
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
|
US20080261905A1
(en)
|
2004-11-08 |
2008-10-23 |
K.U. Leuven Research And Development |
Modified Nucleosides for Rna Interference
|
CA2588607A1
(fr)
|
2004-11-23 |
2006-06-01 |
Ptc Therapeutics, Inc. |
Derives de carbazole, de carboline et d'indole utilises dans l'inhibition de la production de vegf
|
US7838657B2
(en)
*
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
US8354476B2
(en)
|
2004-12-10 |
2013-01-15 |
Kala Pharmaceuticals, Inc. |
Functionalized poly(ether-anhydride) block copolymers
|
US9068969B2
(en)
|
2004-12-28 |
2015-06-30 |
Ptc Therapeutics, Inc. |
Cell based methods and systems for the identification of RNA regulatory sequences and compounds that modulate their functions
|
US8535702B2
(en)
|
2005-02-01 |
2013-09-17 |
Boston Scientific Scimed, Inc. |
Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
|
EP2290363B1
(fr)
|
2005-03-11 |
2014-01-08 |
Firalis SAS |
Biomarqueurs pour des effets secondaires cardio-vasculaires induits par des composés inhibiteurs de cox-2
|
US8415325B2
(en)
|
2005-03-31 |
2013-04-09 |
University Of Delaware |
Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels
|
WO2006110585A2
(fr)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
Genes lies au cancer (prlr)
|
AU2006235276A1
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
CACNA1E in cancer diagnosis, detection and treatment
|
WO2006110776A2
(fr)
|
2005-04-12 |
2006-10-19 |
Nektar Therapeutics Al, Corporation |
Compositions a base de polymere et conjugues d'agents antimicrobiens
|
US20060241076A1
(en)
|
2005-04-26 |
2006-10-26 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
CN101213297B
(zh)
|
2005-05-09 |
2013-02-13 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及单独使用或与其它免疫治疗剂联合使用抗pd-1抗体来治疗癌症的方法
|
US20070072175A1
(en)
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
US20060265771A1
(en)
|
2005-05-17 |
2006-11-23 |
Lewis David L |
Monitoring microrna expression and function
|
DE102005023170A1
(de)
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
JP2008541770A
(ja)
|
2005-06-03 |
2008-11-27 |
ジェネンテック・インコーポレーテッド |
改変したフコシル化レベルを有する抗体の産生方法
|
US7550264B2
(en)
|
2005-06-10 |
2009-06-23 |
Datascope Investment Corporation |
Methods and kits for sense RNA synthesis
|
EP2279758B1
(fr)
|
2005-06-16 |
2015-02-25 |
Nektar Therapeutics |
Conjugués dotés d'un lien dégradable et réactifs polymères utiles à leur préparation
|
US8202835B2
(en)
|
2005-06-17 |
2012-06-19 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
US20110182805A1
(en)
|
2005-06-17 |
2011-07-28 |
Desimone Joseph M |
Nanoparticle fabrication methods, systems, and materials
|
KR20080025181A
(ko)
|
2005-06-30 |
2008-03-19 |
아케믹스 코포레이션 |
완전 2'-변형된 핵산 전사체를 생성하기 위한 물질 및 방법
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
US20080220471A1
(en)
|
2005-07-27 |
2008-09-11 |
Genentech, Inc. |
Vectors and Methods Using Same
|
ES2735531T3
(es)
|
2005-08-23 |
2019-12-19 |
Univ Pennsylvania |
ARN que contiene nucleósidos modificados y métodos de uso del mismo
|
US9012219B2
(en)
*
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
US20070048741A1
(en)
|
2005-08-24 |
2007-03-01 |
Getts Robert C |
Methods and kits for sense RNA synthesis
|
ATE499112T1
(de)
|
2005-09-01 |
2011-03-15 |
Celgene Corp |
Immunologische verwendungen von immunmodulatorischen verbindungen für einen impfstoff und therapie gegen infektionskrankheiten
|
JP5135220B2
(ja)
|
2005-09-01 |
2013-02-06 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
血清群c髄膜炎菌を含む複数ワクチン接種
|
US8420605B2
(en)
|
2005-09-07 |
2013-04-16 |
The University Of Strathclyde |
Hydrogel compositions
|
US20120021042A1
(en)
|
2005-09-15 |
2012-01-26 |
Steffen Panzner |
Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
US20070087437A1
(en)
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
US20070105124A1
(en)
|
2005-11-08 |
2007-05-10 |
Getts Robert C |
Methods and kits for nucleic acid amplification
|
WO2007057167A2
(fr)
|
2005-11-18 |
2007-05-24 |
Bioline Limited |
Procede permettant d’accroitre des reactions enzymatiques d’adn polymerase
|
KR20080090406A
(ko)
|
2005-11-28 |
2008-10-08 |
젠맵 에이/에스 |
재조합 1가 항체 및 그의 제조 방법
|
CA2639819C
(fr)
|
2005-11-30 |
2012-10-23 |
Epicentre Technologies Corporation |
Marquage terminal selectif d'acides nucleiques
|
TWI389709B
(zh)
|
2005-12-01 |
2013-03-21 |
Novartis Ag |
經皮治療系統
|
EP1954252B1
(fr)
|
2005-12-02 |
2016-02-03 |
GlaxoSmithKline Biologicals SA |
Nanoparticules destinees a etre utilisees dans des compositions immunogenes
|
US8603457B2
(en)
|
2005-12-02 |
2013-12-10 |
University Of Rochester |
Nonsense suppression and genetic codon alteration by targeted modification
|
US7579318B2
(en)
|
2005-12-06 |
2009-08-25 |
Centre De La Recherche De La Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
WO2007069090A2
(fr)
|
2005-12-06 |
2007-06-21 |
Centre National De La Recherche Scientifique |
Peptides de pénétration cellulaire pour la délivrance intracellulaire de molécules
|
US8158360B2
(en)
|
2005-12-08 |
2012-04-17 |
Novartis Ag |
Effects of inhibitors of FGFR3 on gene transcription
|
EP2206724A1
(fr)
|
2005-12-13 |
2010-07-14 |
Kyoto University |
Facteur de reprogrammation nucléaire
|
AU2006325030B2
(en)
|
2005-12-16 |
2012-07-26 |
Cellectis |
Cell penetrating peptide conjugates for delivering nucleic acids into cells
|
CA2636867C
(fr)
|
2006-01-13 |
2015-12-01 |
The Trustees Of The University Of Pennsylvania |
Vaccins et produits immunotherapeutiques utilisant une il-15 optimisee par un codon et leurs procedes d'utilisation
|
US20070178103A1
(en)
|
2006-01-30 |
2007-08-02 |
Fey Georg H |
CD19-specific immunotoxin and treatment method
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
DE102006007433A1
(de)
|
2006-02-17 |
2007-08-23 |
Curevac Gmbh |
Adjuvanz in Form einer Lipid-modifizierten Nukleinsäure
|
WO2007097561A1
(fr)
|
2006-02-20 |
2007-08-30 |
Ewha University - Industry Collaboration Foundation |
Peptide présentant une activité de pénétration de membrane cellulaire
|
CN103030801B
(zh)
|
2006-02-21 |
2015-07-22 |
尼克塔治疗公司 |
嵌段可降解聚合物及由其制备的轭合物
|
US20080038278A1
(en)
|
2006-02-24 |
2008-02-14 |
Jingsong Cao |
GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase
|
EP1991204A2
(fr)
|
2006-02-24 |
2008-11-19 |
Novartis AG |
Microparticules contenant un polymère biodégradable et un polysaccharide cationique pour emploi dans des compositions immunogènes
|
US7910152B2
(en)
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
EP4276469A3
(fr)
|
2006-02-28 |
2024-01-17 |
Biogen MA Inc. |
Procédés de traitement de maladies inflammatoires et auto-immunes avec du natalizumab
|
GB0605217D0
(en)
|
2006-03-15 |
2006-04-26 |
Novartis Ag |
Method and compositions for assessing acute rejection
|
WO2007109244A2
(fr)
|
2006-03-21 |
2007-09-27 |
Morehouse School Of Medicine |
Nouvelles nanoparticules destinees a la delivrance d'agents actifs
|
EP2007435B1
(fr)
|
2006-03-31 |
2019-12-18 |
Massachusetts Institute Of Technology |
Système pour l'administration ciblée d'agents thérapeutiques
|
AU2007240986A1
(en)
|
2006-04-04 |
2007-11-01 |
Stc.Unm |
Swellable particles for drug delivery
|
EP1852127A1
(fr)
|
2006-05-02 |
2007-11-07 |
Charité - Universitätsmedizin Berlin |
Utilisation d'un anticorps à action déplétive des cellules B pour le traitement des infections par le virus de polyoma
|
CA2652280C
(fr)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymeres pour particules fonctionnelles
|
KR20090019810A
(ko)
|
2006-05-24 |
2009-02-25 |
라보라뚜와르 세로노 에스. 에이. |
다발성 경화증 치료를 위한 클라드리빈 요법
|
CN104356230A
(zh)
|
2006-06-02 |
2015-02-18 |
哈佛大学校长及研究员协会 |
蛋白质表面重建
|
JP5605895B2
(ja)
|
2006-07-04 |
2014-10-15 |
ゲンマブ エー/エス |
Copdを処置するためのcd20結合分子
|
ATE503469T1
(de)
|
2006-07-07 |
2011-04-15 |
Univ Aarhus |
Nanoteilchen zur abgabe von nukleinsäure
|
AU2007272558B2
(en)
|
2006-07-12 |
2010-12-09 |
Novartis Ag |
Actinically crosslinkable copolymers for manufacturing contact lenses
|
JP2009544287A
(ja)
|
2006-07-20 |
2009-12-17 |
ノバルティス アーゲー |
癌を処置、診断、または検出するためのamigo−2インヒビター
|
WO2008013785A2
(fr)
|
2006-07-24 |
2008-01-31 |
Singh-Broemer And Company, Inc. |
Formulation de nanoparticules solides de substances pharmaceutiques insolubles dans l'eau avec mûrissement d'ostwald réduit
|
CA2659301A1
(fr)
|
2006-07-28 |
2008-02-07 |
Applera Corporation |
Analogues de coiffes de nucleotide d'arnm
|
DE102006035618A1
(de)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
JP2010507361A
(ja)
|
2006-07-31 |
2010-03-11 |
キュアバック ゲーエムベーハー |
具体的には免疫刺激剤/アジュバントとしての、一般式(I):GlXmGn、または一般式(II):ClXmCnで表される核酸
|
AR062271A1
(es)
|
2006-08-07 |
2008-10-29 |
Genzyme Corp |
Uso de una cantidad efectiva de al menos un inhibidor de cxcr4, al menos un agonista de cxcr2 y g-csf para movilizar las celulas progenitoras y/o celulas madre
|
US20080076701A1
(en)
|
2006-08-18 |
2008-03-27 |
Nastech Pharmaceutical Company Inc. |
Dicer substrate rna peptide conjugates and methods for rna therapeutics
|
US8658211B2
(en)
|
2006-08-18 |
2014-02-25 |
Arrowhead Madison Inc. |
Polyconjugates for in vivo delivery of polynucleotides
|
AU2007292221B2
(en)
|
2006-09-06 |
2013-08-29 |
The Regents Of The University Of California |
Selectively targeted antimicrobial peptides and the use thereof
|
MY170607A
(en)
|
2006-09-07 |
2019-08-20 |
Crucell Holland Bv |
Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
|
CA2663003C
(fr)
|
2006-09-08 |
2018-02-13 |
Justin Hanes |
Compositions et methodes destinees a ameliorer le transport a travers le mucus
|
US8454948B2
(en)
|
2006-09-14 |
2013-06-04 |
Medgenics Medical Israel Ltd. |
Long lasting drug formulations
|
GB0619182D0
(en)
|
2006-09-29 |
2006-11-08 |
Leuven K U Res & Dev |
Oligonucleotide arrays
|
MX2009003548A
(es)
|
2006-10-03 |
2009-04-15 |
Alnylam Pharmaceuticals Inc |
Formulaciones que contienen lipidos.
|
BRPI0715299A2
(pt)
|
2006-10-05 |
2013-07-23 |
The Johns Hopkins University |
mÉtodo para preparar nanoparticulas polimÉricas, mÉtodod para preparar uma coposiÇço micelar, micelas polimÉricas reconstituÍveis, composiÇço polimÉrica bioativa de nanopartÍculas, mÉtodo para proporcionar um medicamento a um paciente e processo para preparar composiÇÕes de nanoparticulas polimÉricas
|
DE102006051516A1
(de)
*
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
US7999087B2
(en)
|
2006-11-15 |
2011-08-16 |
Agilent Technologies, Inc. |
2′-silyl containing thiocarbonate protecting groups for RNA synthesis
|
US8242258B2
(en)
|
2006-12-03 |
2012-08-14 |
Agilent Technologies, Inc. |
Protecting groups for RNA synthesis
|
US8399007B2
(en)
|
2006-12-05 |
2013-03-19 |
Landec Corporation |
Method for formulating a controlled-release pharmaceutical formulation
|
US7893227B2
(en)
|
2006-12-05 |
2011-02-22 |
Lasergen, Inc. |
3′-OH unblocked nucleotides and nucleosides base modified with non-cleavable, terminating groups and methods for their use in DNA sequencing
|
WO2008068631A2
(fr)
|
2006-12-06 |
2008-06-12 |
Novartis Ag |
Vaccins comprenant un antigène issu de quatre souches du virus grippal
|
US9034348B2
(en)
|
2006-12-11 |
2015-05-19 |
Chi2Gel Ltd. |
Injectable chitosan mixtures forming hydrogels
|
BRPI0720476B1
(pt)
|
2006-12-18 |
2022-05-31 |
Acceleron Pharma Inc |
Uso de um polipeptídeo de actrii para tratar anemia em um paciente humano
|
US8268586B2
(en)
|
2006-12-21 |
2012-09-18 |
Novozymes, Inc. |
Modified messenger RNA stabilizing sequences for expressing genes in bacterial cells
|
CA2671925A1
(fr)
|
2006-12-21 |
2008-07-10 |
Stryker Corporation |
Formulations a liberation entretenue comprenant des cristaux, des gels macromoleculaires et des suspensions particulaires d'agents biologiques
|
WO2008078180A2
(fr)
|
2006-12-22 |
2008-07-03 |
Archemix Corp. |
Matériaux et procédés pour la génération de transcrits comprenant des nucléotides modifiés
|
DE102006061015A1
(de)
|
2006-12-22 |
2008-06-26 |
Curevac Gmbh |
Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
|
US8338166B2
(en)
|
2007-01-04 |
2012-12-25 |
Lawrence Livermore National Security, Llc |
Sorting, amplification, detection, and identification of nucleic acid subsequences in a complex mixture
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
WO2008091799A2
(fr)
|
2007-01-22 |
2008-07-31 |
The Trustees Of Columbia University In The City Of New York |
Procédés basés sur des cellules, destinés à identifier des inhibiteurs de mutants lrrk2 associés à la maladie de parkinson
|
EP2423220B1
(fr)
|
2007-01-30 |
2015-04-29 |
Epivax, Inc. |
Épitopes de lymphocytes t régulateurs, compositions et utilisations de ceux-ci
|
TW201940502A
(zh)
|
2007-02-02 |
2019-10-16 |
美商艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
US8859229B2
(en)
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
WO2008096370A2
(fr)
|
2007-02-05 |
2008-08-14 |
Natco Pharma Limited |
Méthode nouvelle et efficace de purification de hg-csf de recombinaison
|
US8333799B2
(en)
|
2007-02-12 |
2012-12-18 |
C. R. Bard, Inc. |
Highly flexible stent and method of manufacture
|
US8242087B2
(en)
|
2007-02-27 |
2012-08-14 |
K.U.Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
EP1964922A1
(fr)
|
2007-03-02 |
2008-09-03 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Amélioration de production de protéine
|
TWI419902B
(zh)
|
2007-03-02 |
2013-12-21 |
百靈佳殷格翰製藥公司 |
蛋白質產製之改良
|
JP5249248B2
(ja)
|
2007-03-05 |
2013-07-31 |
ワシントン ユニバーシティー |
膜組み込みペプチドのためのナノ粒子輸送システム
|
JP2010521966A
(ja)
|
2007-03-20 |
2010-07-01 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
α4β7インテグリンに結合するヒト化免疫グロブリンをコードする核酸
|
EP2136788B1
(fr)
|
2007-03-30 |
2011-10-26 |
Bind Biosciences, Inc. |
Ciblage de cellules cancéreuses utilisant des nanoparticules
|
NZ580997A
(en)
|
2007-04-27 |
2011-08-26 |
Echo Therapeutics Inc |
Dermal abrasion device with feedback electrode to deliver data on skin thickness and removable abrasion heads
|
PT2152290E
(pt)
|
2007-04-30 |
2014-09-03 |
Glaxosmithkline Llc |
Métodos para administrar anticorpos anti-il-5
|
WO2008135855A2
(fr)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticules contenant un inhibiteur de la protéine de transfert d'ester de cholestéryle et un polymère non ionisable
|
DK2494993T3
(en)
|
2007-05-04 |
2018-11-12 |
Marina Biotech Inc |
Amino acid lipids and uses thereof
|
US7682789B2
(en)
|
2007-05-04 |
2010-03-23 |
Ventana Medical Systems, Inc. |
Method for quantifying biomolecules conjugated to a nanoparticle
|
WO2009023311A2
(fr)
|
2007-05-07 |
2009-02-19 |
Alba Therapeutics Corporation |
Apport transcutané d'agents thérapeutiques
|
JP5296328B2
(ja)
|
2007-05-09 |
2013-09-25 |
独立行政法人理化学研究所 |
1本鎖環状rnaおよびその製造方法
|
DK2476689T3
(en)
|
2007-05-10 |
2016-01-18 |
Agilent Technologies Inc |
Thiocarbonbeskyttende groups for RNA synthesis
|
NO3072525T3
(fr)
|
2007-05-14 |
2018-06-30 |
|
|
WO2008144365A2
(fr)
|
2007-05-17 |
2008-11-27 |
Novartis Ag |
Procédé de fabrication de compositions de poudre sèche contenant des acides nucléiques
|
BRPI0812384A2
(pt)
|
2007-05-22 |
2014-12-02 |
Novartis Ag |
Métodos de tratamento, diagnóstico e detecção de distúrbios associados a fgf21
|
MX2009013046A
(es)
|
2007-05-30 |
2010-02-17 |
Univ Northwestern |
Nanoparticulas con grupo funcional de acido nucleico para aplicaciones terapeuticas.
|
CA2688539A1
(fr)
|
2007-05-30 |
2008-12-11 |
The General Hospital Corporation |
Procedes de generation de cellules pluripotentes a partir de cellules somatiques
|
CN104072561B
(zh)
|
2007-06-19 |
2017-12-22 |
路易斯安那州州立大学及农业机械学院管理委员会 |
信使rna帽的抗‑反向硫代磷酸类似物的合成和用途
|
WO2009006438A2
(fr)
|
2007-06-29 |
2009-01-08 |
Epicentre Technologies Corporation |
Adn de copie et arn sens
|
WO2009015071A1
(fr)
|
2007-07-23 |
2009-01-29 |
Dharmacon, Inc. |
Criblage de bains inhibiteurs d'agrégat de micro-arn
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
WO2009024599A1
(fr)
|
2007-08-23 |
2009-02-26 |
Novartis Ag |
Procédés pour détecter des oligonucléotides
|
US20110243931A1
(en)
|
2007-09-02 |
2011-10-06 |
Thomas Friess |
Combination therapy with type i and type ii anti-cd20 antibodies
|
WO2009030254A1
(fr)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes d'arn et de peptides cationiques pour transfection et immunostimulation
|
US8506928B2
(en)
|
2007-09-07 |
2013-08-13 |
The Regents Of The University Of California |
Methods and compounds for targeting tissues
|
CA2715078C
(fr)
|
2007-09-26 |
2019-07-23 |
Intrexon Corporation |
Regions non traduites 5' (5'utr) synthetiques, vecteurs d'expression, et procedes pour augmenter l'expression transgenique
|
US8394763B2
(en)
|
2007-09-26 |
2013-03-12 |
Oregon Health & Science University |
Cyclic undecapeptides and derivatives as multiple sclerosis therapies
|
EP2042193A1
(fr)
|
2007-09-28 |
2009-04-01 |
Biomay AG |
Vaccins RNA
|
WO2009046388A1
(fr)
|
2007-10-03 |
2009-04-09 |
United States Medical Research & Material Command |
Peptide p28 liant le cr-2 utilisé comme adjuvant moléculaire pour vaccins à adn
|
WO2009046739A1
(fr)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition pour traiter le cancer de la prostate (pca)
|
WO2009046738A1
(fr)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition pour traiter le cancer du poumon, notamment les cancers du poumon non à petites cellules (nsclc)
|
CN105770878A
(zh)
|
2007-10-12 |
2016-07-20 |
麻省理工学院 |
疫苗纳米技术
|
US20090098118A1
(en)
|
2007-10-15 |
2009-04-16 |
Thomas Friess |
Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent
|
EP2205277B1
(fr)
|
2007-10-22 |
2017-07-26 |
Genmab A/S |
Nouvelles thérapies d'anticorps
|
BRPI0818913A2
(pt)
|
2007-11-01 |
2015-05-12 |
Univ Rochester |
Fator viii recombinante tendo elevada estabilidade
|
RU2491095C2
(ru)
|
2007-11-09 |
2013-08-27 |
Новартис Аг |
Применения анти-cd40-антител
|
WO2009062348A1
(fr)
|
2007-11-14 |
2009-05-22 |
Institute Of Microbiology, Chinese Academy Of Sciences |
Procédés d'inhibition d'une infection par le virus de la grippe et leurs médicaments
|
KR101710472B1
(ko)
|
2007-11-30 |
2017-02-27 |
글락소 그룹 리미티드 |
항원-결합 작제물
|
CA2707042A1
(fr)
|
2007-12-10 |
2009-06-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions et procedes permettant l'inhibition de l'expression du gene du facteur vii
|
SG10201408165WA
(en)
|
2007-12-11 |
2015-01-29 |
Scripps Research Inst |
Compositions and methods related to mrna translational enhancer elements
|
EP2229459B1
(fr)
|
2007-12-13 |
2014-08-27 |
Alnylam Pharmaceuticals, Inc. |
Procédés et compositions de prévention ou de traitement d'infection à virus respiratoire syncytial (RSV)
|
EP2072618A1
(fr)
|
2007-12-14 |
2009-06-24 |
Johannes Gutenberg-Universität Mainz |
Utilisation d'ARN pour la reprogrammation de cellules somatiques
|
WO2009086072A2
(fr)
|
2007-12-21 |
2009-07-09 |
Genentech, Inc. |
Thérapie de patients atteints d'arthrite rhumatoïde réfractaires au rituximab
|
CN102348806A
(zh)
|
2008-01-23 |
2012-02-08 |
味之素株式会社 |
L-氨基酸的生产方法
|
US20100297750A1
(en)
|
2008-01-24 |
2010-11-25 |
Toru Natsume |
Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
|
US9226959B2
(en)
|
2008-01-31 |
2016-01-05 |
Curevac Ag |
Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvant
|
EP2250252A2
(fr)
|
2008-02-11 |
2010-11-17 |
Cambridge Enterprise Limited |
Reprogrammation perfectionnée de cellules de mammifère et cellules ainsi obtenues
|
CA2726861C
(fr)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Dispositifs, formulations et methodes d'administration de plusieurs agents benefiques
|
DE102008009920A1
(de)
|
2008-02-15 |
2009-08-20 |
Aj Innuscreen Gmbh |
Mobiles Gerät für die Nukleinsäureisolierung
|
US20120027813A1
(en)
|
2008-02-22 |
2012-02-02 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted influenza vaccines for pediatric use
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
WO2009108891A2
(fr)
|
2008-02-29 |
2009-09-03 |
Egen, Inc. |
Poloxamères modifiés utilisés pour l’expression génique et méthodes associées
|
EP2265644A4
(fr)
|
2008-03-14 |
2011-04-27 |
Biocon Ltd |
Anticorps monoclonal et procédé correspondant
|
WO2009114854A1
(fr)
|
2008-03-14 |
2009-09-17 |
Egen, Inc. |
Poly(alkylène imines) ramifiées et réticulées, biodégradables
|
AU2009228163B2
(en)
|
2008-03-28 |
2012-08-30 |
Glaxosmithkline Llc |
Methods of treatment
|
WO2010005721A2
(fr)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences, Inc. |
Nanoparticules polymères pharmacologiquement chargées et leurs méthodes de fabrication et d’utilisation
|
CN102119217B
(zh)
|
2008-04-15 |
2015-06-03 |
普洛体维生物治疗公司 |
用于核酸递送的新型制剂
|
WO2009127230A1
(fr)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
Arn(m) modifié pour supprimer ou éviter une réponse immunostimulante et composition immunosuppressive
|
JP5539962B2
(ja)
|
2008-04-25 |
2014-07-02 |
ノースウェスタン、ユニバーシティ |
コレステロールを隔離するのに適したナノ構造体
|
WO2009134808A2
(fr)
|
2008-04-28 |
2009-11-05 |
President And Fellows Of Harvard College |
Protéines fortement chargées utilisées pour la pénétration cellulaire
|
BRPI0913012B1
(pt)
|
2008-04-30 |
2021-12-14 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Quimera de ácido nucleico, métodos para detectar um anticorpo do vírus da dengue em uma amostra de um paciente, e para produzir partículas virais que expressam proteínas prm e e do vírus da dengue, uso de vírus codificado pela quimera e flavivírus ou partícula viral quiméricos
|
US9394538B2
(en)
|
2008-05-07 |
2016-07-19 |
Shi-Lung Lin |
Development of universal cancer drugs and vaccines
|
EP2323716B1
(fr)
|
2008-05-08 |
2015-03-04 |
MiniPumps, LLC |
Pompes d'administration de médicaments
|
US8697098B2
(en)
|
2011-02-25 |
2014-04-15 |
South Dakota State University |
Polymer conjugated protein micelles
|
EP2620161A1
(fr)
|
2008-05-13 |
2013-07-31 |
University of Washington |
Copolymères à deux séquences et complexes polynucléotidiques pour apport dans des cellules
|
JP5689413B2
(ja)
|
2008-05-21 |
2015-03-25 |
ライニッシュ フリードリッヒ−ウィルヘルムズ−ユニバーシタット ボン |
平滑末端を有する5’三リン酸オリゴヌクレオチドおよびその使用
|
JP2011520472A
(ja)
|
2008-05-29 |
2011-07-21 |
ハナル バイオファーマ カンパニー リミテッド |
増加されたタンパク質分解酵素抵抗性を表す修飾型エリスロポエチン(epo)ポリペプチド及びその医薬組成物
|
FR2931824B1
(fr)
|
2008-05-29 |
2014-11-28 |
Centre Nat Rech Scient |
Procede de synthese d'arn par voie chimique.
|
WO2009148528A2
(fr)
|
2008-05-30 |
2009-12-10 |
Millennium Pharmaceuticals, Inc. |
Évaluation d'altérations chromosomiques visant à prédire l'issue d'un traitement au bortézomib
|
PL215513B1
(pl)
|
2008-06-06 |
2013-12-31 |
Univ Warszawski |
Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
US20100104645A1
(en)
|
2008-06-16 |
2010-04-29 |
Bind Biosciences, Inc. |
Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
US20100009424A1
(en)
|
2008-07-14 |
2010-01-14 |
Natasha Forde |
Sonoporation systems and methods
|
WO2010009277A2
(fr)
|
2008-07-15 |
2010-01-21 |
Novartis Ag |
Compositions de peptides amphipatiques immunogènes
|
WO2010009065A2
(fr)
|
2008-07-15 |
2010-01-21 |
Novartis Ag |
Composés organiques
|
PL2319923T3
(pl)
*
|
2008-07-24 |
2014-05-30 |
Meiji Seika Pharma Co Ltd |
Geny biosyntezy pirypiropenu A
|
AU2009290137A1
(en)
|
2008-09-03 |
2010-03-11 |
Xenome Ltd |
Libraries of peptide conjugates and methods for making them
|
EP2342336B1
(fr)
|
2008-09-05 |
2016-12-14 |
President and Fellows of Harvard College |
Evolution dirigée continue de protéines et d'acides nucléiques
|
US8309707B2
(en)
|
2008-09-06 |
2012-11-13 |
Chemgenes Corporation |
RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
|
WO2010027903A2
(fr)
|
2008-09-08 |
2010-03-11 |
Fred Hutchinson Cancer Research Center |
Diagnostic du cancer du poumon
|
US20100087337A1
(en)
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
AR073295A1
(es)
|
2008-09-16 |
2010-10-28 |
Genentech Inc |
Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
|
US20120021519A1
(en)
|
2008-09-19 |
2012-01-26 |
Presidents And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
WO2010037408A1
(fr)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprenant un arnm complexé et un arnm nu pour déclencher ou augmenter une réponse immunostimulante chez un mammifère et utilisations de ladite composition
|
WO2010042490A1
(fr)
|
2008-10-06 |
2010-04-15 |
Boston Medical Center Corporation |
Système de vecteur lentiviral unique pour dérivation de cellules souches pluripotentes induites (ips)
|
CA2740000C
(fr)
|
2008-10-09 |
2017-12-12 |
Tekmira Pharmaceuticals Corporation |
Lipides amines ameliores et procedes d'administration d'acides nucleiques
|
US8535655B2
(en)
|
2008-10-10 |
2013-09-17 |
Polyactiva Pty Ltd. |
Biodegradable polymer—bioactive moiety conjugates
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
WO2010047765A2
(fr)
|
2008-10-20 |
2010-04-29 |
Massachussetts Institute Of Technology |
Nanostructures pour l'administration de médicament
|
WO2010047839A1
(fr)
|
2008-10-25 |
2010-04-29 |
Aura Biosciences |
Particules de virus de plante modifiées et utilisations de celles-ci
|
JP6087504B2
(ja)
|
2008-11-07 |
2017-03-01 |
マサチューセッツ インスティテュート オブ テクノロジー |
アミノアルコールリピドイドおよびその使用
|
KR102344392B1
(ko)
|
2008-11-10 |
2021-12-28 |
알닐람 파마슈티칼스 인코포레이티드 |
치료제 운반용 신규 지질 및 조성물
|
CA2780482A1
(fr)
|
2008-11-17 |
2010-05-10 |
Anil K. Sood |
Particules de hdl pour administration d'acides nucleiques
|
EP2191840A1
(fr)
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Combinaisons antitumorales contenant des anticorps reconnaissant spécifiquement les CD38 et melphalan
|
EP2196476A1
(fr)
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Formulation d'anticorps
|
EP2373382B1
(fr)
|
2008-12-10 |
2017-02-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions d'arndb ciblé sur gnaq et procédés pour inhiber l'expression
|
US8512964B2
(en)
|
2008-12-12 |
2013-08-20 |
The Regents Of The University Of California |
Targets for treatment of hypercholesterolemia
|
WO2010068866A2
(fr)
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Particules thérapeutiques pour administration parentérale, et procédés de fabrication et d'utilisation associés
|
ES2776126T3
(es)
|
2008-12-15 |
2020-07-29 |
Pfizer |
Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
|
SG172792A1
(en)
|
2009-01-16 |
2011-08-29 |
Glaxosmithkline Llc |
Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody
|
WO2010084371A1
(fr)
|
2009-01-26 |
2010-07-29 |
Mitoprod |
Nouvelles molécules d'arn interférent circulaire
|
AU2010208035B2
(en)
|
2009-01-29 |
2016-06-23 |
Arbutus Biopharma Corporation |
Improved lipid formulation for the delivery of nucleic acids
|
WO2010088927A1
(fr)
|
2009-02-09 |
2010-08-12 |
Curevac Gmbh |
Utilisation de pei pour l'amélioration de la libération endosomale et de l'expression d'acides nucléiques transfectés, complexés par des composés cationiques ou polycationiques
|
US20140141089A1
(en)
|
2009-02-11 |
2014-05-22 |
Colorado School Of Mines |
Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
|
WO2010098861A1
(fr)
|
2009-02-24 |
2010-09-02 |
The Scripps Research Institute |
Re-ingénierie de structure primaire d'arnm pour une production améliorée de protéines
|
US8685458B2
(en)
|
2009-03-05 |
2014-04-01 |
Bend Research, Inc. |
Pharmaceutical compositions of dextran polymer derivatives
|
WO2010141135A2
(fr)
|
2009-03-05 |
2010-12-09 |
Trustees Of Boston University |
Bactériophages exprimant des peptides antimicrobiennes et utilisations afférentes
|
WO2010105277A1
(fr)
|
2009-03-13 |
2010-09-16 |
Egen, Inc. |
Compositions et procédés pour l'administration d'arn biologiquement actifs
|
CN102438978B
(zh)
|
2009-03-20 |
2017-02-22 |
Clsn实验室股份有限公司 |
聚胺衍生物
|
US20120095077A1
(en)
|
2009-03-23 |
2012-04-19 |
University Of Utah Research Foundation |
Methods and compositions related to modified guanine bases for controlling off-target effects in rna interference
|
JP5622254B2
(ja)
|
2009-03-31 |
2014-11-12 |
国立大学法人東京大学 |
二本鎖リボ核酸ポリイオンコンプレックス
|
PL2414387T3
(pl)
|
2009-04-03 |
2016-06-30 |
Univ Chicago |
Kompozycje i sposoby związane z wariantami białka A (SpA)
|
US9724404B2
(en)
|
2009-04-13 |
2017-08-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
HPV particles and uses thereof
|
SG175166A1
(en)
|
2009-04-17 |
2011-11-28 |
Biogen Idec Inc |
Compositions and methods to treat acute myelogenous leukemia
|
WO2010123501A1
(fr)
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Suppression immunitaire innée permettant la distribution répétée de longues molécules d'arn
|
NO2424895T3
(fr)
|
2009-04-27 |
2018-02-03 |
|
|
US8287910B2
(en)
|
2009-04-30 |
2012-10-16 |
Intezyne Technologies, Inc. |
Polymeric micelles for polynucleotide encapsulation
|
US8715736B2
(en)
|
2009-04-30 |
2014-05-06 |
Florida Agricultural And Mechanical University |
Nanoparticle formulations for skin delivery
|
NZ621981A
(en)
|
2009-05-05 |
2015-09-25 |
Tekmira Pharmaceuticals Corp |
Lipid compositions
|
DE202009007116U1
(de)
|
2009-05-18 |
2010-10-14 |
Amoena Medizin-Orthopädie-Technik GmbH |
Antidekubituskissen
|
US8574835B2
(en)
|
2009-05-29 |
2013-11-05 |
Life Technologies Corporation |
Scaffolded nucleic acid polymer particles and methods of making and using
|
EP2440556A1
(fr)
|
2009-06-10 |
2012-04-18 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de la phosphatidylinositol 3-kinase
|
EA201791744A3
(ru)
|
2009-06-10 |
2018-07-31 |
Арбутус Биофарма Корпорэйшн |
Улучшенная липидная композиция
|
US8273869B2
(en)
|
2009-06-15 |
2012-09-25 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated dsRNA targeting the PCSK9 gene
|
WO2010151664A2
(fr)
|
2009-06-26 |
2010-12-29 |
Massachusetts Institute Of Technology |
Compositions et procédés pour traiter le cancer et moduler la formation de granules de stress
|
WO2011000106A1
(fr)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Lipides cationiques et procédés améliorés pour l'administration d'agents thérapeutiques
|
CA2767127A1
(fr)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Formulations lipidiques inedites permettant l'administration d'agents therapeutiques en direction de tumeurs solides
|
CA2766907A1
(fr)
|
2009-07-06 |
2011-01-13 |
Novartis Ag |
Molecules d'arn autorepliquantes et leurs utilisations
|
DE102009033507A1
(de)
*
|
2009-07-15 |
2011-01-20 |
Niro-Plan Ag |
Vorrichtung und Verfahren zum Erzeugen von gekühltem Kaffee
|
DK2459231T3
(en)
|
2009-07-31 |
2016-09-05 |
Ethris Gmbh |
RNA with a combination of unmodified and modified nucleotides for protein expression
|
EP2281579A1
(fr)
|
2009-08-05 |
2011-02-09 |
BioNTech AG |
Composition de vaccin comportant un ADN modifié 5'-Cap
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
US20110070227A1
(en)
|
2009-09-18 |
2011-03-24 |
Anna-Marie Novotney-Barry |
Treatment of Autoimmune and Inflammatory Diseases
|
US8859284B2
(en)
|
2009-10-22 |
2014-10-14 |
The United States Of America, As Represented By The Secretary Of The Navy |
Delivery of nanoparticles to neurons
|
US8449916B1
(en)
|
2009-11-06 |
2013-05-28 |
Iowa State University Research Foundation, Inc. |
Antimicrobial compositions and methods
|
WO2011060250A1
(fr)
|
2009-11-13 |
2011-05-19 |
Bend Research, Inc. |
Dérivés de polymère de dextrane cationiques
|
US9415113B2
(en)
|
2009-11-18 |
2016-08-16 |
University Of Washington |
Targeting monomers and polymers having targeting blocks
|
US8530429B2
(en)
|
2009-11-24 |
2013-09-10 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
NZ700688A
(en)
|
2009-12-01 |
2016-02-26 |
Shire Human Genetic Therapies |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
US20110245756A1
(en)
|
2009-12-03 |
2011-10-06 |
Rishi Arora |
Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity
|
ES2880038T3
(es)
|
2009-12-06 |
2021-11-23 |
Bioverativ Therapeutics Inc |
Polipéptidos quiméricos e híbridos de factor VIII-Fc, y métodos de uso de los mismos
|
EP3623474A1
(fr)
|
2009-12-07 |
2020-03-18 |
The Trustees of The University of Pennsylvania |
Préparations d'arn comprenant de l'arn modifié purifié de reprogrammation de cellules
|
US20130189741A1
(en)
|
2009-12-07 |
2013-07-25 |
Cellscript, Inc. |
Compositions and methods for reprogramming mammalian cells
|
US9687550B2
(en)
|
2009-12-07 |
2017-06-27 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
WO2011069528A1
(fr)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilisation d'acides nucléiques dans des solutions contenant du lactate
|
WO2011069529A1
(fr)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Solution contenant du mannose pour la lyophilisation, la transfection et/ou l'injection d'acides nucléiques
|
JP5891175B2
(ja)
|
2009-12-11 |
2016-03-22 |
バインド セラピューティックス インコーポレイテッド |
治療用粒子の凍結乾燥に対する安定製剤
|
EA201290497A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Терапевтические полимерные наночастицы, включающие кортикостероиды, и способы получения таковых
|
ES2780156T3
(es)
|
2009-12-15 |
2020-08-24 |
Pfizer |
Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular
|
DE102009058769A1
(de)
|
2009-12-16 |
2011-06-22 |
MagForce Nanotechnologies AG, 10589 |
Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
|
WO2011084620A2
(fr)
|
2009-12-16 |
2011-07-14 |
Brigham And Women's Hospital, Inc. |
Particules pour administration de plusieurs agents
|
ES2749426T3
(es)
|
2009-12-18 |
2020-03-20 |
Univ British Columbia |
Métodos y composiciones para administración de ácidos nucleicos
|
AU2010334911A1
(en)
|
2009-12-23 |
2012-07-12 |
Novartis Ag |
Lipids, lipid compositions, and methods of using them
|
US8846631B2
(en)
|
2010-01-14 |
2014-09-30 |
Regulus Therapeutics Inc. |
MicroRNA compositions and methods
|
EP3023495B1
(fr)
|
2010-02-24 |
2019-05-08 |
Arrowhead Pharmaceuticals, Inc. |
Compositions pour l'administration ciblée d'arnsi
|
WO2011106702A2
(fr)
|
2010-02-25 |
2011-09-01 |
The Johns Hopkins University |
Délivrance prolongée d'agents thérapeutiques à un compartiment oculaire
|
US20130133483A1
(en)
|
2010-03-08 |
2013-05-30 |
University Of Rochester |
Synthesis of Nanoparticles Using Reducing Gases
|
KR20130006663A
(ko)
|
2010-03-16 |
2013-01-17 |
유니버시티 오브 유타 리서치 파운데이션 |
뉴클레오티드 전달을 높이기 위한 환원가능한 폴리(아미도 에틸렌이민)으로의 절단성 변형법
|
WO2011116072A1
(fr)
|
2010-03-16 |
2011-09-22 |
Escape Therapeutics, Inc. |
Compositions de tuteur en hydrogel hybride et leurs procédés d'utilisation
|
US20110230816A1
(en)
|
2010-03-18 |
2011-09-22 |
Tyco Healthcare Group Lp |
Gels for Transdermal Delivery
|
US9149432B2
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
EP2549931B1
(fr)
|
2010-03-24 |
2019-12-04 |
United States Endoscopy Group, Inc. |
Dispositif pour biopsies multiples
|
GB201005005D0
(en)
|
2010-03-25 |
2010-05-12 |
Angeletti P Ist Richerche Bio |
New vaccine
|
WO2011119262A1
(fr)
|
2010-03-26 |
2011-09-29 |
Cerulean Pharma Inc. |
Procédés et systèmes de production de nanoparticules
|
JP2013528665A
(ja)
|
2010-03-26 |
2013-07-11 |
メルサナ セラピューティックス, インコーポレイテッド |
ポリヌクレオチドの送達のための修飾ポリマー、その製造方法、およびその使用方法
|
US20110247090A1
(en)
|
2010-04-02 |
2011-10-06 |
Intrexon Corporation |
Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
EP3391877A1
(fr)
|
2010-04-08 |
2018-10-24 |
The Trustees of Princeton University |
Préparation de nanoparticules lipidiques
|
CN104959087B
(zh)
|
2010-04-09 |
2017-08-15 |
帕西拉制药有限公司 |
用于配制大直径合成膜囊泡的方法
|
US20130071430A1
(en)
|
2010-04-09 |
2013-03-21 |
The University Of Tokyo |
Microrna-controlled recombinant vaccinia virus and use thereof
|
KR101196667B1
(ko)
|
2010-04-15 |
2012-11-02 |
포항공과대학교 산학협력단 |
피에이치 민감성 금속 나노 입자를 이용한 항암제 전달 시스템
|
CA2796464C
(fr)
|
2010-04-16 |
2021-08-03 |
Immune Disease Institute, Inc. |
Expression de polypeptide prolongee a partir d'arn synthetiques modifies et utilisations de celle-ci
|
EP2377938A1
(fr)
|
2010-04-16 |
2011-10-19 |
Eukarys |
Enzymes ARN-polymérases susceptibles de coiffage et leurs applications
|
LT2558577T
(lt)
|
2010-04-16 |
2019-03-12 |
Nuevolution A/S |
Bifunkciniai kompleksai ir tokių kompleksų gamybos ir naudojimo būdai
|
US20130260460A1
(en)
|
2010-04-22 |
2013-10-03 |
Isis Pharmaceuticals Inc |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
MX2012012567A
(es)
|
2010-04-28 |
2012-11-21 |
Kimberly Clark Co |
Metodo para aumentar la permeabilidad de una barrera epitelial.
|
WO2011139911A2
(fr)
|
2010-04-29 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Arn simple brin à formulation lipidique
|
AU2011245372A1
(en)
|
2010-04-30 |
2012-11-29 |
Novartis Ag |
Predictive markers useful in the treatment of Fragile X Syndrome (FXS)
|
US9254327B2
(en)
|
2010-05-10 |
2016-02-09 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
US10077232B2
(en)
|
2010-05-12 |
2018-09-18 |
Arbutus Biopharma Corporation |
Cyclic cationic lipids and methods of use
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
EP2387999A1
(fr)
|
2010-05-21 |
2011-11-23 |
CureVac GmbH |
Solution contenant de l'histidine pour la transfection et/ou l'injection d'acides nucléiques et utilisations associées
|
US8802863B2
(en)
|
2010-05-24 |
2014-08-12 |
Sirna Therapeutics, Inc. |
Amino alcohol cationic lipids for oligonucleotide delivery
|
EP2575767B1
(fr)
|
2010-06-04 |
2017-01-04 |
Sirna Therapeutics, Inc. |
Nouveaux lipides cationiques de faible poids moléculaire pour l'administration d'oligonucléotides
|
EP2579899B1
(fr)
|
2010-06-14 |
2017-03-15 |
F. Hoffmann-La Roche AG |
Peptides pénétrant dans la cellule et leurs utilisations
|
US20130236968A1
(en)
|
2010-06-21 |
2013-09-12 |
Alnylam Pharmaceuticals, Inc. |
Multifunctional copolymers for nucleic acid delivery
|
US10478483B2
(en)
|
2010-06-25 |
2019-11-19 |
Glaxosmithkline Biologicals Sa |
Combinations of meningococcal factor H binding proteins
|
EP2589391B1
(fr)
|
2010-07-01 |
2018-11-14 |
Rosetta Exosome Co., Ltd. |
Microvésicules de cellules bactériennes pour application dans le traitement du cancer
|
KR20130093084A
(ko)
|
2010-07-02 |
2013-08-21 |
더 유니버시티 오브 시카고 |
단백질 A(SpA) 변이체와 관련된 조성물 및 방법
|
DK3243526T3
(da)
|
2010-07-06 |
2020-02-17 |
Glaxosmithkline Biologicals Sa |
Levering af rna til at udløse flere immunsignalveje
|
WO2012006369A2
(fr)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Immunisation de grands mammifères à l'aide de faibles doses d'arn
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
EP2590626B1
(fr)
|
2010-07-06 |
2015-10-28 |
GlaxoSmithKline Biologicals SA |
Liposomes à lipides ayant une valeur de pka avantageuse pour la délivrance d'arn
|
RS63817B1
(sr)
|
2010-07-06 |
2023-01-31 |
Glaxosmithkline Biologicals Sa |
Čestice za isporuku slične virionu za molekule samoreplicirajuće rnk
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
JP6025721B2
(ja)
|
2010-07-06 |
2016-11-16 |
ノバルティス アーゲー |
カチオン性水中油型エマルジョン
|
CN103140237A
(zh)
|
2010-07-09 |
2013-06-05 |
比奥根艾迪克依蒙菲利亚公司 |
因子ix多肽及其使用方法
|
WO2012006623A1
(fr)
|
2010-07-09 |
2012-01-12 |
Biogen Idec Hemophilia Inc. |
Systèmes pour le traitement du facteur viii et procédés associés
|
US20130177523A1
(en)
|
2010-07-13 |
2013-07-11 |
University Of Utah Research Foundation |
Gold particles and methods of making and using the same in cancer treatment
|
GB201012410D0
(en)
|
2010-07-23 |
2010-09-08 |
Medical Res Council |
Intracellular immunity
|
EP2449113B8
(fr)
|
2010-07-30 |
2015-11-25 |
CureVac AG |
Complexation d'acides nucléiques avec des composants cationiques réticulés par des liaisons disulfure pour la transfection et l'immunostimulation
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2012021516A2
(fr)
|
2010-08-09 |
2012-02-16 |
The Trustees Of The University Of Pennsylvania |
Structures hybrides nanoparticulaires-oligonucléotidiques et leurs méthodes d'utilisation
|
WO2012019630A1
(fr)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Acide nucléique comprenant ou codant pour une tige-boucle d'histone et une séquence poly(a) ou un signal de polyadénylation pour augmenter l'expression d'une protéine codée
|
EP2605799A4
(fr)
|
2010-08-20 |
2014-02-26 |
Cerulean Pharma Inc |
Conjugués, particules, compositions et procédés associés
|
ES2531577T3
(es)
|
2010-08-20 |
2015-03-17 |
Novartis Ag |
Conjuntos de agujas para la administración de vacuna soluble contra la gripe
|
EP2605816B1
(fr)
|
2010-08-20 |
2019-01-23 |
University Of Washington |
Pulvérisateur circonférentiel pour administration de médicaments à l'épithélium olfactif et au cerveau
|
CN103221549A
(zh)
|
2010-08-31 |
2013-07-24 |
默沙东公司 |
用于递送寡核苷酸的新型简单化学实体和方法
|
PL2611467T3
(pl)
|
2010-08-31 |
2022-08-16 |
Glaxosmithkline Biologicals Sa |
Małe liposomy do dostarczania rna kodującego immunogen
|
EP4119155A1
(fr)
|
2010-08-31 |
2023-01-18 |
GlaxoSmithKline Biologicals S.A. |
Liposomes pegylés pour la délivrance d'arn codant pour un immunogène
|
BR112013004865A2
(pt)
|
2010-08-31 |
2016-06-07 |
Novartis Ag |
lípidos adequados para entrega lipossomal de codificadores de proteínas rna
|
EP2926830B1
(fr)
|
2010-08-31 |
2017-08-02 |
Theraclone Sciences, Inc. |
Anticorps de neutralisation du virus de l'immunodéficience humaine (vih)
|
WO2012031205A2
(fr)
|
2010-09-03 |
2012-03-08 |
The Brigham And Women's Hospital, Inc. |
Particules hybrides lipide-polymère
|
WO2012034077A2
(fr)
|
2010-09-09 |
2012-03-15 |
The University Of Chicago |
Compositions et procédés relatifs à des souches de staphylocoques atténuées
|
US9095540B2
(en)
|
2010-09-09 |
2015-08-04 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
WO2012039979A2
(fr)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Diffusion rapide de grosses nanoparticules polymères dans le cerveau de mammifères
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
ES2888231T3
(es)
|
2010-09-20 |
2022-01-03 |
Sirna Therapeutics Inc |
Lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos
|
WO2012038448A1
(fr)
|
2010-09-21 |
2012-03-29 |
Riboxx Gmbh |
Procédé pour synthétiser de l'arn en utilisant une matrice d'adn
|
EP4079292A1
(fr)
|
2010-09-24 |
2022-10-26 |
The Brigham and Women's Hospital, Inc. |
Gels nanostructurés capables de libération contrôlée d'agents encapsulés
|
WO2012050975A2
(fr)
|
2010-09-29 |
2012-04-19 |
The University Of North Carolina At Chapel Hill |
Nouvelles molécules d'arn circulaire de mammifère et utilisations associées
|
JP2013545723A
(ja)
|
2010-09-30 |
2013-12-26 |
メルク・シャープ・エンド・ドーム・コーポレイション |
オリゴヌクレオチドの送達のための低分子量カチオン性脂質
|
HUE058896T2
(hu)
|
2010-10-01 |
2022-09-28 |
Modernatx Inc |
N1-metil-pszeudo-uracilt tartalmazó ribonukleinsavak és azok felhasználásai
|
US10078075B2
(en)
|
2011-12-09 |
2018-09-18 |
Vanderbilt University |
Integrated organ-on-chip systems and applications of the same
|
JP2013545727A
(ja)
|
2010-10-21 |
2013-12-26 |
メルク・シャープ・アンド・ドーム・コーポレーション |
オリゴヌクレオチド送達用の新規低分子量カチオン性脂質
|
SG189048A1
(en)
|
2010-10-29 |
2013-05-31 |
Merck Sharp & Dohme |
Recombinant subunit dengue virus vaccine
|
WO2012061703A1
(fr)
|
2010-11-05 |
2012-05-10 |
The Johns Hopkins University |
Compositions et procédés visant à une réduction de la mucoadhérence
|
CN103201386A
(zh)
|
2010-11-09 |
2013-07-10 |
加利福尼亚大学董事会 |
皮肤穿透及细胞进入(space)肽及其使用方法
|
JP6077450B2
(ja)
|
2010-11-12 |
2017-02-08 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
コンセンサス前立腺抗原、それをコードする核酸分子、ならびにそれを含むワクチンおよび用途
|
AU2011329850B2
(en)
|
2010-11-16 |
2017-03-02 |
Selecta Biosciences, Inc. |
Immunostimulatory oligonucleotides
|
HUE039747T2
(hu)
|
2010-11-17 |
2019-02-28 |
Aduro Biotech Inc |
Eljárások és kompozíciók EGFRVIII-ra való immunválasz indukálására
|
CN107012149A
(zh)
|
2010-11-19 |
2017-08-04 |
艾德拉药物股份有限公司 |
调控基于toll‑样受体的免疫应答的免疫调节寡核苷酸(iro)化合物
|
US8853377B2
(en)
|
2010-11-30 |
2014-10-07 |
Shire Human Genetic Therapies, Inc. |
mRNA for use in treatment of human genetic diseases
|
WO2012072096A1
(fr)
|
2010-12-03 |
2012-06-07 |
Biontech Ag |
Procédé pour l'expression cellulaire d'arn
|
EP2651445A2
(fr)
|
2010-12-16 |
2013-10-23 |
SPRNA GmbH |
Composition pharmaceutique à base d'arn qui comprend un métal alcalin en tant que contre-ion et formulé avec des dications
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
US9394537B2
(en)
|
2010-12-22 |
2016-07-19 |
President And Fellows Of Harvard College |
Continuous directed evolution
|
WO2012089225A1
(fr)
|
2010-12-29 |
2012-07-05 |
Curevac Gmbh |
Combinaison de vaccination et d'inhibition de la présentation des antigènes restreinte par le cmh de classe i
|
CA3131967A1
(fr)
|
2010-12-29 |
2012-07-05 |
F. Hoffman-La Roche Ag |
Conjugues de petites molecules pour l'administration intracellulaire d'acides nucleiques
|
CA2862765A1
(fr)
|
2011-01-04 |
2012-07-12 |
Brown University |
Nanotubes utilises comme transporteurs d'acides nucleiques dans des cellules
|
WO2012094574A2
(fr)
|
2011-01-06 |
2012-07-12 |
The Johns Hopkins University |
Nanoparticules de polyribonucléotide stabilisées
|
WO2012094653A2
(fr)
|
2011-01-07 |
2012-07-12 |
Massachusetts Institute Of Technology |
Compositions et procédés pour l'administration de médicament macromoléculaire
|
EP2663548B1
(fr)
|
2011-01-11 |
2017-04-05 |
Alnylam Pharmaceuticals, Inc. |
Lipides pégylés et leur utilisation pour une administration de médicament
|
US20120189700A1
(en)
|
2011-01-19 |
2012-07-26 |
Zoraida Aguilar |
Nanoparticle Based Immunological Stimulation
|
JP2014505064A
(ja)
|
2011-01-26 |
2014-02-27 |
セニックス バイオサイエンス ゲーエムベーハー |
自然に存在する細胞内輸送経路を介して化合物を送達するための送達システム及びコンジュゲート
|
US10363309B2
(en)
|
2011-02-04 |
2019-07-30 |
Case Western Reserve University |
Targeted nanoparticle conjugates
|
US20140066363A1
(en)
|
2011-02-07 |
2014-03-06 |
Arun K. Bhunia |
Carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide
|
WO2012116715A1
(fr)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination chez des nouveaux-nés et des enfants en bas âge
|
US20120207840A1
(en)
|
2011-02-10 |
2012-08-16 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
|
CN103703013A
(zh)
|
2011-02-14 |
2014-04-02 |
斯威夫特生物科学公司 |
多核苷酸引物和探针
|
JP6054308B2
(ja)
|
2011-02-15 |
2016-12-27 |
メリマック ファーマシューティカルズ, インコーポレイテッドMerrimack Pharmaceuticals, Inc. |
核酸を細胞へ送達する組成物及び方法
|
WO2012112689A1
(fr)
|
2011-02-15 |
2012-08-23 |
The University Of North Carolina At Chapel Hill |
Nanoparticules, liposomes, polymères, agents et protéines modifiés avec des lieurs réversibles
|
EP2489371A1
(fr)
|
2011-02-18 |
2012-08-22 |
Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria |
Support peptidique pour l'administration de médicaments
|
WO2012113413A1
(fr)
|
2011-02-21 |
2012-08-30 |
Curevac Gmbh |
Composition de vaccin comprenant des acides nucléiques immunostimulateurs complexés et des antigènes emballés avec des conjugués de polyéthylèneglycol/peptide à liaison disulfure
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達
|
US8696637B2
(en)
|
2011-02-28 |
2014-04-15 |
Kimberly-Clark Worldwide |
Transdermal patch containing microneedles
|
WO2012116714A1
(fr)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination chez des patients âgés
|
BR112013022397A2
(pt)
|
2011-03-02 |
2017-09-26 |
Derek OHagan |
vacinas combinadas com doses menores de antígeno e/ou adjuvante
|
WO2012122318A2
(fr)
|
2011-03-07 |
2012-09-13 |
Massachusetts Institute Of Technology |
Procédés pour transfecter des cellules avec des acides nucléiques
|
WO2012125680A1
(fr)
|
2011-03-16 |
2012-09-20 |
Novartis Ag |
Méthodes de traitement de vascularite à l'aide d'un molécule de liaison à l'il-17
|
EP2686442A1
(fr)
|
2011-03-17 |
2014-01-22 |
Novartis AG |
Fgfr et ses ligands utilisés comme biomarqueurs du cancer du sein chez des sujets rh positifs
|
US20140212503A1
(en)
|
2011-03-17 |
2014-07-31 |
Hyukjin Lee |
Delivery system
|
ES2785108T3
(es)
|
2011-03-24 |
2020-10-05 |
Glaxosmithkline Biologicals Sa |
Nanoemulsiones adyuvantes con fosfolípidos
|
EP2691443B1
(fr)
|
2011-03-28 |
2021-02-17 |
Massachusetts Institute of Technology |
Lipomères conjugués et utilisations associées
|
WO2012131594A1
(fr)
|
2011-03-28 |
2012-10-04 |
Novartis Ag |
Marqueurs associés aux inhibiteurs des kinases dépendantes des cyclines
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
EP3460064B8
(fr)
|
2011-04-03 |
2024-03-20 |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
Expression protéique efficace in vivo à l'aide d'arn modifié (mod-arn)
|
US9284343B2
(en)
|
2011-04-04 |
2016-03-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
2′-O-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides
|
WO2012142132A1
(fr)
|
2011-04-11 |
2012-10-18 |
Life Technologies Corporation |
Particules polymères et méthodes pour leur fabrication et leur utilisation
|
WO2012142240A1
(fr)
|
2011-04-13 |
2012-10-18 |
The Trustees Of The University Of Pennsylvania |
Nanoparticules mésoporeuses revêtues
|
WO2013158127A1
(fr)
|
2012-04-16 |
2013-10-24 |
Molecular Transfer, Inc. |
Agents permettant d'améliorer l'administration d'acides nucléiques dans des cellules eucaryotes
|
US20140178894A1
(en)
|
2011-04-20 |
2014-06-26 |
Novartis Forschungsstiftung, Zweigniederlassung |
Culture medium suitable for the culture of undifferentiated cells
|
EA034702B1
(ru)
|
2011-04-26 |
2020-03-10 |
Молекулар Экспресс, Инк. |
Липосомные композиции
|
AU2012249474A1
(en)
|
2011-04-28 |
2013-11-07 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
US20160272697A2
(en)
|
2011-04-28 |
2016-09-22 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Neutralizing Antibodies to Nipah and Hendra Virus
|
JP2014515759A
(ja)
|
2011-04-29 |
2014-07-03 |
ノバルティス アーゲー |
扁平上皮がんを治療する方法関連出願
|
CN107261154A
(zh)
|
2011-04-29 |
2017-10-20 |
西莱克塔生物科技公司 |
致耐受性合成纳米载体
|
EP3777538B1
(fr)
|
2011-05-02 |
2023-06-28 |
Wayne State University |
Technique d'utilisation de cellules souches pluripotentes induites par les protéines
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
CN103547350A
(zh)
|
2011-05-10 |
2014-01-29 |
巴斯夫欧洲公司 |
水包油乳液
|
EP2707033A1
(fr)
|
2011-05-11 |
2014-03-19 |
Ramot at Tel Aviv University, Ltd. |
Conjugués polymères ciblés et leurs utilisations
|
DK2706988T3
(da)
|
2011-05-12 |
2020-01-20 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Liposomer omfattende polymer konjugerede lipider og relateret brug
|
WO2012152910A1
(fr)
|
2011-05-12 |
2012-11-15 |
Helmut Vockner |
Nouvelle formulation pharmaceutique
|
CA2835644C
(fr)
|
2011-05-13 |
2021-06-15 |
Novartis Ag |
Antigenes de pre-fusion f du vrs
|
CN103687957A
(zh)
|
2011-05-17 |
2014-03-26 |
现代治疗公司 |
工程化核酸及其用于非人类脊椎动物的方法
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
US8978170B2
(en)
|
2011-05-20 |
2015-03-17 |
Kohler Co. |
Toilet installation system and method
|
JP2014516531A
(ja)
|
2011-05-25 |
2014-07-17 |
ノバルティス アーゲー |
肺癌に対するバイオマーカー
|
WO2012166923A2
(fr)
|
2011-05-31 |
2012-12-06 |
Bind Biosciences |
Nanoparticules polymères chargées de médicament et leurs procédés de fabrication et d'utilisation
|
KR20140026537A
(ko)
|
2011-06-02 |
2014-03-05 |
노파르티스 아게 |
헤지호그 억제제 요법을 위한 바이오마커
|
EP2714017B1
(fr)
|
2011-06-02 |
2018-08-01 |
The Regents of The University of California |
Nanoparticules encapsulées dans une membrane et leur procédé d'utilisation
|
EP2717911A1
(fr)
|
2011-06-06 |
2014-04-16 |
Novartis Forschungsstiftung, Zweigniederlassung |
Protéine tyrosine phosphatase de type non-récepteur 11 (ptpn11), et cancer du sein triple négatif
|
JP6184945B2
(ja)
|
2011-06-08 |
2017-08-23 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
mRNA送達のための脂質ナノ粒子組成物および方法
|
AU2012267578B2
(en)
|
2011-06-08 |
2017-04-20 |
Translate Bio, Inc. |
Cleavable lipids
|
WO2012168491A1
(fr)
|
2011-06-10 |
2012-12-13 |
Novartis Ag |
Formulations pharmaceutiques d'antagonistes de pcsk9
|
WO2012170607A2
(fr)
|
2011-06-10 |
2012-12-13 |
Novartis Ag |
Utilisation d'antagonistes de pcsk9
|
US8636696B2
(en)
|
2011-06-10 |
2014-01-28 |
Kimberly-Clark Worldwide, Inc. |
Transdermal device containing microneedles
|
US8916696B2
(en)
|
2011-06-12 |
2014-12-23 |
City Of Hope |
Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use
|
WO2012172495A1
(fr)
|
2011-06-14 |
2012-12-20 |
Novartis Ag |
Compositions et procédés de ciblage du tem8 par des anticorps
|
CN103717249B
(zh)
|
2011-06-15 |
2017-03-22 |
克洛恩泰克制药股份公司 |
注射针和装置
|
BR112013031762A2
(pt)
|
2011-06-16 |
2016-09-13 |
Novartis Ag |
proteínas solúveis para utilização como terapêuticos
|
JP6113155B2
(ja)
|
2011-06-20 |
2017-04-12 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
計算で最適化した広い反応性を示すh1n1インフルエンザの抗原
|
WO2013003475A1
(fr)
|
2011-06-27 |
2013-01-03 |
Cellscript, Inc. |
Inhibition d'une réponse immunitaire innée
|
KR102436439B1
(ko)
|
2011-06-28 |
2022-08-25 |
이노비오 파마수티컬즈, 인크. |
최소 침습 피부 전기천공 장치
|
JP6472999B2
(ja)
|
2011-07-01 |
2019-02-20 |
ノバルティス アーゲー |
代謝障害を治療するための方法
|
EP2729182A4
(fr)
|
2011-07-04 |
2014-12-24 |
Commw Scient Ind Res Org |
Complexe d'acide nucléique
|
CA2841047A1
(fr)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Compositions immunogenes et leurs utilisations
|
JP2014520806A
(ja)
|
2011-07-06 |
2014-08-25 |
ノバルティス アーゲー |
Rna分子の送達のための有用なn:p比を有するリポソーム
|
RU2606846C2
(ru)
|
2011-07-06 |
2017-01-10 |
Новартис Аг |
Эмульсии типа "масло в воде", которые содержат нуклеиновые кислоты
|
ES2702318T3
(es)
|
2011-07-06 |
2019-02-28 |
Glaxosmithkline Biologicals Sa |
Emulsiones catiónicas de aceite en agua
|
CA2840989A1
(fr)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Compositions de combinaisons immunogenes et utilisations de celles-ci
|
WO2013006824A2
(fr)
|
2011-07-07 |
2013-01-10 |
Life Technologies Corporation |
Particules polymères, particules polymères d'acide nucléique et leurs procédés de préparation et d'utilisation
|
US20130012566A1
(en)
|
2011-07-10 |
2013-01-10 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia
|
WO2013009736A2
(fr)
|
2011-07-10 |
2013-01-17 |
President And Fellows Of Harvard College |
Compositions et procédés d'auto-assemblage de polymères avec des unités d'échelle macroscopiques et microscopiques complémentaires
|
WO2013009717A1
(fr)
|
2011-07-10 |
2013-01-17 |
Elisabet De Los Pinos |
Nanoparticules de protéine virionique pour l'administration d'agents diagnostiques ou thérapeutiques pour le traitement de maladies cutanées
|
US20140148503A1
(en)
|
2011-07-20 |
2014-05-29 |
University Of Iowa Research Foundation |
Nucleic acid aptamers
|
GB2492999A
(en)
|
2011-07-20 |
2013-01-23 |
Univ Central Lancashire |
Neutron detector
|
CN103732211B
(zh)
|
2011-07-21 |
2017-03-01 |
禾大国际股份公开有限公司 |
支化的聚醚‑聚酰胺嵌段共聚物及其制造与使用方法
|
EP2736921B1
(fr)
|
2011-07-25 |
2018-06-27 |
GlaxoSmithKline Biologicals SA |
Compositions et procédés d'évaluation de l'immunogénicité fonctionnelle de vaccins contre un parvovirus
|
US9493549B2
(en)
|
2011-07-25 |
2016-11-15 |
The Rockefeller University |
Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
|
CN109172819A
(zh)
|
2011-07-29 |
2019-01-11 |
西莱克塔生物科技公司 |
产生体液和细胞毒性t淋巴细胞(ctl)免疫应答的合成纳米载体
|
EP2744517B1
(fr)
|
2011-08-15 |
2019-03-13 |
The University of Chicago |
Compositions et procédés liés aux anticorps anti-protéine a du staphylocoque
|
US8932572B2
(en)
|
2011-08-26 |
2015-01-13 |
Arrowhead Madison Inc. |
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
|
MX366055B
(es)
|
2011-08-31 |
2019-06-26 |
Novartis Ag |
Liposomas pegilados para admistracion de acido ribonucleico (arn) que codifica para inmunogeno.
|
US9126966B2
(en)
|
2011-08-31 |
2015-09-08 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
CN103930135A
(zh)
|
2011-08-31 |
2014-07-16 |
马林克罗特有限公司 |
使用h-膦酸酯的纳米颗粒peg修饰
|
WO2013033620A1
(fr)
|
2011-09-01 |
2013-03-07 |
Irm Llc |
Composés et compositions pouvant être utilisés en tant qu'inhibiteurs des kinases pdgfr
|
EP3521432A1
(fr)
|
2011-09-02 |
2019-08-07 |
Arrowhead Pharmaceuticals, Inc. |
Compositions organiques de traitement de maladies associées à hsf1
|
WO2013039857A1
(fr)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Acides nucléiques modifiés et leurs procédés d'utilisation
|
EP3384938A1
(fr)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Acides nucléiques techniques et leurs procédés d'utilisation
|
TR201909110T4
(tr)
|
2011-09-14 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
|
US20150017245A1
(en)
|
2011-09-22 |
2015-01-15 |
Bind Therapeutics, Inc. |
Methods of treating cancers with therapeutic nanoparticles
|
US9375388B2
(en)
|
2011-09-23 |
2016-06-28 |
Indian Institute Of Technology, Bombay |
Nanoparticle based cosmetic composition
|
TW201315742A
(zh)
|
2011-09-26 |
2013-04-16 |
Novartis Ag |
治療代謝病症之雙功能蛋白質
|
TWI593708B
(zh)
|
2011-09-26 |
2017-08-01 |
諾華公司 |
治療代謝病症之融合蛋白質
|
EP2760477B1
(fr)
|
2011-09-27 |
2018-08-08 |
Alnylam Pharmaceuticals, Inc. |
Lipides di-aliphatiques pegylés substitués
|
WO2013045505A1
(fr)
|
2011-09-28 |
2013-04-04 |
Novartis Ag |
Biomarqueurs pour traitement combiné par des agents sraa
|
RS62993B1
(sr)
|
2011-10-03 |
2022-03-31 |
Modernatx Inc |
Modifikovani nukleozidi, nukleotidi, i nukleinske kiseline, i njihove upotrebe
|
AU2012322704B2
(en)
|
2011-10-11 |
2017-09-07 |
Novartis Ag |
Recombinant self-replicating polycistronic RNA molecules
|
WO2013055971A1
(fr)
|
2011-10-11 |
2013-04-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Polymères pour administrer une substance dans une cellule
|
EP2766407B1
(fr)
|
2011-10-12 |
2018-06-27 |
The Curators Of The University Of Missouri |
Polymères pentablocs
|
US20190209690A9
(en)
|
2011-10-12 |
2019-07-11 |
The Johns Hopkins University |
Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery
|
SG11201401499XA
(en)
|
2011-10-14 |
2014-09-26 |
Stc Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
|
US9296826B2
(en)
|
2011-10-14 |
2016-03-29 |
Novartis Ag |
Antibodies and methods for WNT pathway-related diseases
|
CA2852917C
(fr)
|
2011-10-18 |
2020-07-07 |
Dicerna Pharmaceuticals, Inc. |
Lipides cationiques amines et utilisations associees
|
US20140371717A1
(en)
|
2011-10-18 |
2014-12-18 |
Micell Technologies, Inc. |
Drug delivery medical device
|
CN103930112B
(zh)
|
2011-10-20 |
2018-11-09 |
诺华股份有限公司 |
预测对α7烟碱型乙酰胆碱受体激活剂疗法的响应的生物标志物
|
US20140248320A1
(en)
|
2011-10-20 |
2014-09-04 |
Novartis Ag |
Adjuvanted influenza b virus vaccines for pediatric priming
|
EP2770980A4
(fr)
|
2011-10-25 |
2015-11-04 |
Univ British Columbia |
Nanoparticules lipides de taille limite, et procédés correspondants
|
WO2013061290A1
(fr)
|
2011-10-26 |
2013-05-02 |
Nanopass Technologies Ltd. |
Dispositif d'administration de médicament intradermique à microaiguille présentant une fonctionnalité d'autoblocage
|
KR102265775B1
(ko)
|
2011-10-27 |
2021-06-16 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
고점도 생체활성 제제의 경피 전달 방법
|
AU2012328570B2
(en)
|
2011-10-27 |
2017-08-31 |
Massachusetts Institute Of Technology |
Amino acid derivatives functionalized on the n-terminus capable of forming drug encapsulating microspheres and uses thereof
|
WO2013062140A1
(fr)
|
2011-10-28 |
2013-05-02 |
Kyoto University |
Procédé pour l'induction efficace de la différenciation de cellules souches pluripotentes en des cellules du lignage hépatique
|
US20140323907A1
(en)
|
2011-10-28 |
2014-10-30 |
Jason Frazier |
Methods for drug delivery
|
MX352823B
(es)
|
2011-10-28 |
2017-12-04 |
Integritybio Inc |
Formulaciones de proteinas que contienen aminoacidos.
|
SI3091029T1
(sl)
|
2011-10-31 |
2023-03-31 |
F. Hoffmann - La Roche Ag |
Pripravki protiteles proti IL13
|
EP2773426B1
(fr)
|
2011-10-31 |
2018-08-22 |
Mallinckrodt LLC |
Compositions liposomales combinatoires pour le traitement du cancer
|
SG11201401964TA
(en)
|
2011-11-04 |
2014-05-29 |
Agency Science Tech & Res |
Self-assembled composite ultrasmall peptide-polymer hydrogels
|
WO2013067537A1
(fr)
|
2011-11-04 |
2013-05-10 |
Univertiy Of Notre Dame Du Lac |
Administration d'un médicament à l'aide d'une nanoparticule
|
US9579338B2
(en)
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
TW201323442A
(zh)
|
2011-11-04 |
2013-06-16 |
Novartis Ag |
低密度脂蛋白相關蛋白6(lrp6)-半衰期延長構築體
|
EP2773328A2
(fr)
|
2011-11-04 |
2014-09-10 |
Nitto Denko Corporation |
Procédé de fabrication de nanoparticules lipidiques pour une administration de médicament
|
US20130116408A1
(en)
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
US20130115247A1
(en)
|
2011-11-05 |
2013-05-09 |
Aura Biosciences, Inc. |
Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
|
WO2013070872A1
(fr)
|
2011-11-08 |
2013-05-16 |
The Board Of Trustees Of The University Of Arkansas |
Procédés et compositions pour la libération induite par rayons x de liposomes sensibles au ph
|
US20140287510A1
(en)
|
2011-11-08 |
2014-09-25 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute |
Rod cell-specific promoter
|
WO2013068432A1
(fr)
|
2011-11-08 |
2013-05-16 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
Diagnostic précoce de maladies neurodégénératives
|
US20140314787A1
(en)
|
2011-11-08 |
2014-10-23 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute |
Treatment for neurodegenerative diseases
|
US9581590B2
(en)
|
2011-11-09 |
2017-02-28 |
Board Of Trustees Of Michigan State University |
Metallic nanoparticle synthesis with carbohydrate capping agent
|
WO2013071047A1
(fr)
|
2011-11-11 |
2013-05-16 |
Children's Medical Center Corporation |
Compositions et procédés pour la transcription in vitro d'arn
|
US9777043B2
(en)
|
2011-11-11 |
2017-10-03 |
Variation Biotechnologies Inc. |
Compositions and methods for treatment of cytomegalovirus
|
EP2780035A1
(fr)
|
2011-11-14 |
2014-09-24 |
Novartis AG |
Complexes immunogènes de carbomères polyanioniques et de polypeptides env et procédés de fabrication et d'utilisation de ceux-ci
|
JP2014533294A
(ja)
|
2011-11-15 |
2014-12-11 |
ノバルティス アーゲー |
ホスホイノシチド3−キナーゼ阻害剤およびヤヌスキナーゼ2−シグナル伝達兼転写活性化因子5経路の調節剤の組合せ
|
DK2790681T4
(da)
|
2011-11-18 |
2023-05-01 |
Regeneron Pharma |
Fremgangsmåde til fremstilling af en farmaceutisk formulering med langvarig frigivelse omfattende polymercoatede proteinmikropartikler ved anvendelse af spraytørring
|
JP2015504430A
(ja)
|
2011-11-21 |
2015-02-12 |
ノバルティス アーゲー |
Il−7アンタゴニスト及びpsa応答又は非応答対立遺伝子を用いた乾癬性関節炎(psa)を治療する方法
|
WO2013078199A2
(fr)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Méthodes pour une administration in vivo améliorée d'arn synthétiques modifiés
|
EP2785326A2
(fr)
|
2011-11-29 |
2014-10-08 |
The University of North Carolina at Chapel Hill |
Particules manipulées de façon géométrique et procédés de modulation de réponses des macrophages ou immunitaires
|
US9364549B2
(en)
|
2011-11-30 |
2016-06-14 |
Andreas Voigt |
Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
|
KR102143435B1
(ko)
|
2011-11-30 |
2020-08-11 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
펩티드 치료제 및 아미노산을 포함하는 마이크로니들 장치 및 이의 제조 및 사용 방법
|
MX351453B
(es)
|
2011-12-02 |
2017-10-16 |
Pegasus Laboratories Inc |
Composiciones de liberacion sostenida a base de lipidos anfipaticos.
|
WO2013082529A1
(fr)
|
2011-12-02 |
2013-06-06 |
Yale University |
Synthèse enzymatique de poly(amine-co-esters) et ses méthodes d'utilisation pour une libération de gènes
|
US20130142781A1
(en)
|
2011-12-02 |
2013-06-06 |
Invivo Therapeutics Corporation |
Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealants
|
RU2691027C2
(ru)
|
2011-12-05 |
2019-06-07 |
Фэктор Байосайенс Инк. |
Способы и препараты для трансфекции клеток
|
WO2013085951A1
(fr)
|
2011-12-05 |
2013-06-13 |
Nano Precision Medical, Inc. |
Dispositif possédant une membrane pour nanotube en dioxyde de titane destiné à l'administration de médicament
|
US8497124B2
(en)
|
2011-12-05 |
2013-07-30 |
Factor Bioscience Inc. |
Methods and products for reprogramming cells to a less differentiated state
|
ES2921724T1
(es)
|
2011-12-07 |
2022-08-31 |
Alnylam Pharmaceuticals Inc |
Lípidos biodegradables para la administración de agentes activos
|
US20140308304A1
(en)
|
2011-12-07 |
2014-10-16 |
Alnylam Pharmaceuticals, Inc. |
Lipids for the delivery of active agents
|
GB201121070D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
composition for delivery of biotherapeutics
|
WO2013086322A1
(fr)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Lipides biodégradables ramifiés à terminaisons alkyle et cycloalkyle destinés à l'administration d'agents actifs
|
US9725687B2
(en)
|
2011-12-09 |
2017-08-08 |
President And Fellows Of Harvard College |
Integrated human organ-on-chip microphysiological systems
|
EP2787977A4
(fr)
|
2011-12-09 |
2015-05-06 |
Univ California |
Encapsulation liposomale de médicaments
|
WO2013086502A1
(fr)
|
2011-12-09 |
2013-06-13 |
President And Fellows Of Harvard College |
Puces à organes et leurs utilisations
|
CA2858694A1
(fr)
|
2011-12-12 |
2013-06-20 |
Kyowa Hakko Kirin Co., Ltd. |
Nanoparticules lipidiques contenant des associations de lipides cationiques
|
CA2858884A1
(fr)
|
2011-12-12 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Proteines comprenant la pbp2a de sarm et des fragments de celle-ci, acides nucleiques codant pour celles-ci, et compositions et leur utilisation pour la prevention et le traitement d'infections par le sarm
|
JP6182457B2
(ja)
|
2011-12-12 |
2017-08-16 |
協和発酵キリン株式会社 |
カチオン性脂質を含有するドラックデリバリーシステムのための脂質ナノ粒子
|
RS61161B1
(sr)
|
2011-12-13 |
2021-01-29 |
Engeneic Molecular Delivery Pty Ltd |
Intaktne minićelije poreklom iz bakterija za isporuku terapijskih agenasa tumorima mozga
|
EP2604253A1
(fr)
|
2011-12-13 |
2013-06-19 |
Otto Glatter |
Émulsion eau dans l'huile et leurs procédés de préparation
|
US20150000936A1
(en)
|
2011-12-13 |
2015-01-01 |
Schlumberger Technology Corporation |
Energization of an element with a thermally expandable material
|
EP2791364A4
(fr)
|
2011-12-14 |
2015-11-11 |
Moderna Therapeutics Inc |
Procédés de réponse à une menace biologique
|
WO2013087083A1
(fr)
|
2011-12-15 |
2013-06-20 |
Biontech Ag |
Particules comprenant un arn simple brin et un arn double brin à des fins d'immunomodulation
|
US20140349320A1
(en)
|
2011-12-15 |
2014-11-27 |
The Trustees Of The University Of Pennsylvania |
Using Adaptive Immunity to Detect Drug Resistance
|
AU2012351947B2
(en)
|
2011-12-16 |
2017-08-17 |
Novartis Ag |
Aerosolization apparatus for inhalation profile-independent drug delivery
|
US9580501B2
(en)
|
2011-12-16 |
2017-02-28 |
Synthon Biopharmaceuticals B.V. |
Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases
|
CA2859583C
(fr)
|
2011-12-16 |
2020-02-18 |
Allergan, Inc. |
Compositions ophtalmiques comprenant des copolymeres greffes polyvinyl caprolactame-poly(acetate de vinyle)-polyethylene glycol
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
EA201491185A1
(ru)
|
2011-12-16 |
2015-05-29 |
Массачусетс Инститьют Оф Текнолоджи |
Полимеры альфа-аминоамидинов и их применение
|
WO2013090601A2
(fr)
|
2011-12-16 |
2013-06-20 |
Massachusetts Institute Of Technology |
Nanoparticules compactes pour des applications biologiques
|
EP2794701B1
(fr)
|
2011-12-19 |
2017-03-08 |
The University Of Sydney |
Composite peptide-hydrogel
|
US9241829B2
(en)
|
2011-12-20 |
2016-01-26 |
Abbott Medical Optics Inc. |
Implantable intraocular drug delivery apparatus, system and method
|
CA2859691A1
(fr)
|
2011-12-21 |
2013-06-27 |
Moderna Therapeutics, Inc. |
Procedes d'augmentation de la viabilite ou de la longevite d'un organe ou d'un explant d'organe
|
US20130195851A1
(en)
|
2011-12-23 |
2013-08-01 |
Genentech, Inc. |
Articles of manufacture and methods for co-administration of antibodies
|
WO2013101908A1
(fr)
|
2011-12-27 |
2013-07-04 |
Massachusetts Institute Of Technology |
Dispositifs à micro-aiguilles et leurs utilisations
|
WO2013098589A1
(fr)
|
2011-12-29 |
2013-07-04 |
Novartis Ag |
Combinaisons avec adjuvant de protéines méningococciques liant le facteur h
|
WO2013103842A1
(fr)
|
2012-01-06 |
2013-07-11 |
Michigan Life Therapeutics, Llc |
Méthodes de réduction du risque de maladie cardiovasculaire
|
CN108977412A
(zh)
|
2012-01-26 |
2018-12-11 |
生命科技公司 |
用于提高病毒感染性的方法
|
KR20140128966A
(ko)
|
2012-01-26 |
2014-11-06 |
라이프 테크놀로지스 코포레이션 |
바이러스의 감염성을 증가시키는 방법
|
WO2013113325A1
(fr)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Complexes chargés négativement comprenant des acides nucléiques pour l'immunostimulation
|
WO2013113326A1
(fr)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Composition pharmaceutique comprenant un complexe support polymère - charge et au moins un antigène de protéine ou de peptide
|
EP2623121A1
(fr)
|
2012-01-31 |
2013-08-07 |
Bayer Innovation GmbH |
Composition pharmaceutique comportant un complexe de chargement de porteur polymérique et un antigène
|
KR102081560B1
(ko)
|
2012-02-09 |
2020-02-25 |
라이프 테크놀로지스 코포레이션 |
친수성 중합체성 입자 및 그의 제조 방법
|
WO2013126564A1
(fr)
|
2012-02-22 |
2013-08-29 |
Cerulean Pharma Inc. |
Conjugués, particules, compositions, et procédés associés
|
US20130243867A1
(en)
|
2012-02-23 |
2013-09-19 |
University Of South Florida (A Florida Non-Profit Corporation) |
Micelle compositions and methods for their use
|
WO2013130535A1
(fr)
|
2012-02-27 |
2013-09-06 |
Newgen Biopharma Corporation |
Administration locale de nano-formulations hormonale et non hormonale, procédés pour leur fabrication et leur utilisation
|
WO2013128027A1
(fr)
|
2012-03-01 |
2013-09-06 |
Amgen Research (Munich) Gmbh |
Molécules de liaison à un polypeptide à longue durée de vie
|
WO2013136234A1
(fr)
|
2012-03-13 |
2013-09-19 |
University Of Kwazulu-Natal |
Dispositifs d'administration transdermique
|
US10322089B2
(en)
|
2012-03-14 |
2019-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nanoparticles, nanoparticle delivery methods, and systems of delivery
|
CA2867381C
(fr)
|
2012-03-16 |
2016-09-20 |
The Johns Hopkins University |
Formulations a liberation controlee pour l'administration d'inhibiteurs du hif-1
|
EP2825156B1
(fr)
|
2012-03-16 |
2017-07-26 |
Merck Patent GmbH |
Ciblage avec des acides aminés lipidiques
|
CN104394891B
(zh)
|
2012-03-16 |
2019-04-16 |
约翰霍普金斯大学 |
用于递送活性剂的非线性多嵌段共聚物-药物结合物
|
US9610346B2
(en)
|
2012-03-23 |
2017-04-04 |
International Aids Vaccine Initiative |
Recombinant viral vectors
|
WO2013142349A1
(fr)
|
2012-03-23 |
2013-09-26 |
University Of Chicago |
Compositions et méthodes associées à la sbi staphylococcique
|
WO2013143555A1
(fr)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Formulation d'arn pour immunothérapie
|
US9717685B2
(en)
|
2012-03-26 |
2017-08-01 |
President And Fellows Of Harvard College |
Lipid-coated nucleic acid nanostructures of defined shape
|
DK3578659T3
(da)
|
2012-03-27 |
2024-02-05 |
CureVac SE |
Kunstige nukelinsyremolekyler til forbedret protein- eller peptidekspression
|
SG10201607962RA
(en)
|
2012-03-27 |
2016-11-29 |
Curevac Ag |
Artificial nucleic acid molecules
|
WO2013148541A1
(fr)
|
2012-03-27 |
2013-10-03 |
Merck Sharp & Dohme Corp. |
Lipides cationiques biodégradables à base de diéther pour l'administration de petit arni
|
MX358706B
(es)
|
2012-03-27 |
2018-08-31 |
Curevac Ag |
Moleculas de acido nucleico artificiales que comprenden un top 5´utr.
|
US9877919B2
(en)
|
2012-03-29 |
2018-01-30 |
Translate Bio, Inc. |
Lipid-derived neutral nanoparticles
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
JP2015518705A
(ja)
|
2012-04-02 |
2015-07-06 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
ヒト疾患に関連する生物製剤およびタンパク質の産生のための修飾ポリヌクレオチド
|
WO2013151650A1
(fr)
|
2012-04-05 |
2013-10-10 |
University Of Florida Research Foundation, Inc. |
Nanoparticules neurophiles
|
WO2013151771A1
(fr)
|
2012-04-05 |
2013-10-10 |
Massachusetts Institute Of Technology |
Compositions immunostimulatrices et leurs procédés d'utilisation
|
WO2013152351A2
(fr)
|
2012-04-06 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Polypeptides de fusion et procédés pour les utiliser
|
CN104379127A
(zh)
|
2012-04-08 |
2015-02-25 |
席拉蔻公司 |
制备用于治疗泌尿上皮失调的热可逆凝胶制剂
|
US20130296531A1
(en)
|
2012-04-11 |
2013-11-07 |
Intezyne Technologies, Inc. |
Block copolymers for stable micelles
|
WO2013155493A1
(fr)
|
2012-04-12 |
2013-10-17 |
Yale University |
Méthode de traitement de maladies et de troubles inflammatoires et auto-immuns
|
WO2013154766A1
(fr)
|
2012-04-13 |
2013-10-17 |
New York University |
Régulation par micro-arn de la voie du récepteur des ldl
|
US11001797B2
(en)
|
2012-04-13 |
2021-05-11 |
President And Fellows Of Harvard College |
Devices and methods for in vitro aerosol delivery
|
CN103764153A
(zh)
|
2012-04-18 |
2014-04-30 |
箭头研究公司 |
用于体内核酸递送的聚(丙烯酸酯)聚合物
|
AU2013249548A1
(en)
|
2012-04-19 |
2014-11-06 |
Sirna Therapeutics, Inc. |
Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
|
US10278927B2
(en)
|
2012-04-23 |
2019-05-07 |
Massachusetts Institute Of Technology |
Stable layer-by-layer coated particles
|
EA030211B1
(ru)
|
2012-04-25 |
2018-07-31 |
Регьюлэс Терапьютикс Инк. |
Соединения на основе микрорнк и способы модулирования активности mir-21
|
KR102140989B1
(ko)
|
2012-05-03 |
2020-08-04 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
US9889208B2
(en)
|
2012-05-04 |
2018-02-13 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
US20150087671A1
(en)
|
2012-05-16 |
2015-03-26 |
Micell Technologies, Inc. |
Low burst sustained release lipophilic and biologic agent compositions
|
US9399672B2
(en)
|
2012-05-17 |
2016-07-26 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Hepatitis C virus neutralizing antibody
|
WO2013173693A1
(fr)
|
2012-05-18 |
2013-11-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoparticules ayant une entrée améliorée dans des cellules cancéreuses
|
KR102169891B1
(ko)
|
2012-05-23 |
2020-10-26 |
더 오하이오 스테이트 유니버시티 |
지질 나노입자 조성물 및 이를 제조하는 방법 및 사용하는 방법
|
EP2854857B1
(fr)
|
2012-05-25 |
2018-11-28 |
CureVac AG |
Immobilisation réversible et/ou libération contrôlée de nanoparticules contenant des acides nucléiques par le biais de revêtements de polymère (biodégradable)
|
WO2013184945A1
(fr)
|
2012-06-06 |
2013-12-12 |
Loma Vista Medical, Inc. |
Dispositifs médicaux gonflables
|
BR112014029807A2
(pt)
|
2012-06-08 |
2017-06-27 |
Ethris Gmbh |
administração pulmonar de rna mensageiro
|
EA201492055A1
(ru)
|
2012-06-08 |
2015-11-30 |
Шир Хьюман Дженетик Терапис, Инк. |
ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
|
PT2858974T
(pt)
|
2012-06-08 |
2018-11-29 |
Nitto Denko Corp |
Lípidos para formulações de administração de agentes terapêuticos
|
JP6275707B2
(ja)
|
2012-06-20 |
2018-02-07 |
フランク・グー |
粘膜付着性ナノ粒子送達系
|
US20150218252A1
(en)
|
2012-06-20 |
2015-08-06 |
President And Fellows Of Harvard College |
Self-assembling peptides, peptide nanostructures and uses thereof
|
US9803010B2
(en)
|
2012-06-27 |
2017-10-31 |
Merck Sharp & Dohme Corp. |
Crystalline anti-human IL-23p19 antibodies
|
US9956291B2
(en)
|
2012-07-10 |
2018-05-01 |
Shaker A. Mousa |
Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
|
EP2872120B1
(fr)
|
2012-07-16 |
2017-05-03 |
Nanoderm Sciences, Inc. |
Nanoparticules thérapeutiques portant une polymyxine b en tant qu'agent ciblant
|
EP2687251A1
(fr)
|
2012-07-17 |
2014-01-22 |
Sanofi-Aventis Deutschland GmbH |
Dispositif d'administration de médicaments
|
EP2687252A1
(fr)
|
2012-07-17 |
2014-01-22 |
Sanofi-Aventis Deutschland GmbH |
Dispositif d'administration de médicaments
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
WO2014015334A1
(fr)
|
2012-07-20 |
2014-01-23 |
Brown University |
Système et procédés pour administration protégée par nanostructure d'agent de traitement et libération sélective de celui-ci
|
KR20160073936A
(ko)
|
2012-07-24 |
2016-06-27 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 나노구조의 자기-조립
|
GB201213624D0
(en)
|
2012-07-27 |
2012-09-12 |
Univ Ulster The |
Method and system for production of conjugated nanoparticles
|
WO2014015422A1
(fr)
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Nanoparticules à base de cellulose pour administration de médicament
|
US9931418B2
(en)
|
2012-08-07 |
2018-04-03 |
Northeastern University |
Compositions for the delivery of RNA and drugs into cells
|
WO2014024193A1
(fr)
|
2012-08-07 |
2014-02-13 |
Prodel Pharma Ltd. |
Compositions et procédés d'administration rapide, à travers les muqueuses, d'ingrédients pharmaceutiques
|
WO2014025312A1
(fr)
|
2012-08-08 |
2014-02-13 |
Nanyang Technological University |
Procédés de fabrication de microparticules d'hydrogel associées à des cellules vivantes, et compositions utilisées pour fabriquer un échafaudage pour l'ingénierie tissulaire
|
AU2013299537A1
(en)
|
2012-08-08 |
2015-02-19 |
Presage Biosciences, Inc. |
Extrusion methods and devices for drug delivery
|
EP2882459A1
(fr)
|
2012-08-10 |
2015-06-17 |
University of North Texas Health Science Center |
Véhicule d'administration de médicament comprenant des conjugués entre des acides polyaminés de ciblage et des acides gras
|
CA2884870C
(fr)
|
2012-08-13 |
2022-03-29 |
Massachusetts Institute Of Technology |
Lipidoides contenant des amines et leurs utilisations
|
WO2014027006A1
(fr)
|
2012-08-13 |
2014-02-20 |
Edko Pazarlama Tanitim Ticaret Limited Sirketi |
Formulations bioadhésives destinées à être utilisées dans l'administration de médicaments
|
US9775804B2
(en)
|
2012-08-14 |
2017-10-03 |
Aaron Froese |
Internal structured self assembling liposomes
|
US9827321B2
(en)
|
2012-08-14 |
2017-11-28 |
The Trustees Of The University Of Pennsylvania |
Stabilizing shear-thinning hydrogels
|
EP2885414B1
(fr)
|
2012-08-15 |
2020-09-23 |
The University of Chicago |
Produits thérapeutiques à base d'exosome contre des troubles neurodégénératifs
|
WO2014039185A1
(fr)
|
2012-09-05 |
2014-03-13 |
Creighton University |
Nanoparticules polymériques dans un gel thermosensible pour une prophylaxie vaginale du vih indépendante du coït
|
US8703197B2
(en)
|
2012-09-13 |
2014-04-22 |
International Business Machines Corporation |
Branched polyamines for delivery of biologically active materials
|
CN104812381B
(zh)
|
2012-09-17 |
2018-01-26 |
辉瑞大药厂 |
用于制备治疗性纳米颗粒的方法
|
WO2014047649A1
(fr)
|
2012-09-24 |
2014-03-27 |
The Regents Of The University Of California |
Procédés d'agencement et d'empaquetage d'acides nucléiques pour une résistance inhabituelle vis-à-vis de nucléases et une administration ciblée pour une thérapie génique
|
WO2014052634A1
(fr)
|
2012-09-27 |
2014-04-03 |
The University Of North Carolina At Chapel Hill |
Nanoparticules revêtues de lipide contenant des agents ayant de faibles solubilités dans l'eau et les lipides, et procédés associés
|
WO2014053881A1
(fr)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Peptides pénétrant dans les cellules pour l'administration intracellulaire de molécules
|
WO2014053879A1
(fr)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Peptides pénétrant dans les cellules pour l'administration intracellulaire de molécules
|
US20140100178A1
(en)
|
2012-10-04 |
2014-04-10 |
Aslam Ansari |
Composition and methods for site-specific drug delivery to treat malaria and other liver diseases
|
WO2014053880A1
(fr)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Peptides pénétrant dans les cellules pour l'administration intracellulaire de molécules
|
EP2716655A1
(fr)
|
2012-10-04 |
2014-04-09 |
Institut Pasteur |
Nouveaux anticorps neutralisants dirigés contre le virus de l'hépatite C
|
WO2014053882A1
(fr)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Peptides pénétrant dans les cellules pour l'administration intracellulaire de molécules
|
US20150202153A1
(en)
|
2012-10-04 |
2015-07-23 |
University Of The Witwatersrand, Johannesburg |
Liposomal drug delivery system
|
EP2716689A1
(fr)
|
2012-10-05 |
2014-04-09 |
National University of Ireland, Galway |
Polymère présentant plusieurs branches comprenant au moins un disulfure et/ou un groupe vinyle
|
WO2014064534A2
(fr)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Aiguille d'injection, dispositif, compositions immunogènes et procédé d'utilisation
|
WO2014059022A1
(fr)
|
2012-10-09 |
2014-04-17 |
The Brigham And Women's Hospital, Inc. |
Nanoparticules pour l'administration ciblée d'agents thérapeutiques multiples et procédés d'utilisation
|
US20140106260A1
(en)
|
2012-10-11 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Core-shell nanoparticulate compositions and methods
|
WO2014062697A2
(fr)
|
2012-10-16 |
2014-04-24 |
Endocyte, Inc. |
Conjugués d'administration de médicament contenant des acides aminés artificiels et procédés d'utilisation
|
HUE051577T2
(hu)
|
2012-10-18 |
2021-03-01 |
Univ Rockefeller |
Széleskörû semlegesítést biztosító anti-HIV ellenanyagok
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
EP2911697A1
(fr)
|
2012-10-26 |
2015-09-02 |
Nlife Therapeutics S.L. |
Compositions et méthodes d'administration sélective de molécules d'oligonucléotides à des types de cellules
|
US20150272900A1
(en)
|
2012-10-26 |
2015-10-01 |
The Johns Hopkins University |
Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics
|
WO2014066912A1
(fr)
|
2012-10-26 |
2014-05-01 |
Vanderbilt University |
Nanoparticules polymères
|
US20150376581A1
(en)
|
2012-10-29 |
2015-12-31 |
Technische Universitaet Dortmund |
T7 rna polymerase variants and methods of using the same
|
RU2711249C2
(ru)
|
2012-11-01 |
2020-01-15 |
Фэктор Байосайенс Инк. |
Способы и продукты для экспрессии белков в клетках
|
WO2014071072A2
(fr)
|
2012-11-02 |
2014-05-08 |
Pungente Michael D |
Nouveaux lipides cationiques à base de caroténoïde pour la capture cellulaire d'acide nucléique
|
US10017767B2
(en)
|
2012-11-05 |
2018-07-10 |
Fondazione Centro San Raffaele |
Targets in multiple myeloma and other disorders
|
WO2014074597A1
(fr)
|
2012-11-06 |
2014-05-15 |
President And Fellows Of Harvard College |
Compositions et procédés se rapportant à des nanostructures d'acides nucléiques complexes
|
AU2013341646B2
(en)
|
2012-11-06 |
2017-08-31 |
Rochal Technologies, Llc |
Delivery of biologically-active agents using volatile, hydrophobic solvents
|
EP2916873B1
(fr)
|
2012-11-07 |
2017-07-26 |
Council of Scientific & Industrial Research |
Nanocomplexe contenant un peptide amphipathique utile pour la transfection efficace de biomolécules
|
WO2014072999A1
(fr)
|
2012-11-07 |
2014-05-15 |
Council Of Scientific And Industrial Research |
Nanocomplexe contenant un peptide cationique pour l'administration d'une biomolécule
|
TW201428101A
(zh)
|
2012-11-08 |
2014-07-16 |
Inviragen Inc |
登革熱病毒血清型4型之建構物的組成物、方法及用途
|
MX2015005363A
(es)
|
2012-11-08 |
2015-11-06 |
Novozymes Biopharma Dk As |
Variantes de albumina.
|
CN104884049A
(zh)
|
2012-11-08 |
2015-09-02 |
克莱尔塞德生物医学股份有限公司 |
用于在人类受试者中治疗眼部疾病的方法和装置
|
CA2886987C
(fr)
|
2012-11-08 |
2022-07-12 |
Eleven Biotherapeutics, Inc. |
Antagonistes de l'il-6 et leurs utilisations
|
US9200119B2
(en)
|
2012-11-09 |
2015-12-01 |
Momentive Performance Materials Inc. |
Silicon-containing zwitterionic linear copolymer composition
|
TR201809547T4
(tr)
|
2012-11-09 |
2018-07-23 |
Biontech Rna Pharmaceuticals Gmbh |
Hücresel RNA ifadesine yönelik yöntem.
|
WO2014072468A1
(fr)
|
2012-11-09 |
2014-05-15 |
Velin-Pharma A/S |
Compositions pour administration pulmonaire
|
WO2014071963A1
(fr)
|
2012-11-09 |
2014-05-15 |
Biontech Ag |
Procédé pour l'expression d'arn cellulaire
|
GB201220354D0
(en)
|
2012-11-12 |
2012-12-26 |
Medpharm Ltd |
Dermal compositions
|
CA2890190A1
(fr)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Composes et procedes pour produire un conjugue
|
EP2916862B1
(fr)
|
2012-11-12 |
2020-01-08 |
GenVec, Inc. |
Antigènes de la malaria et procédés d'utilisation
|
WO2014078399A1
(fr)
|
2012-11-13 |
2014-05-22 |
Baylor College Of Medicine |
Polymères biodégradables multi-bras pour l'administration d'acides nucléiques
|
US9310374B2
(en)
|
2012-11-16 |
2016-04-12 |
Redwood Bioscience, Inc. |
Hydrazinyl-indole compounds and methods for producing a conjugate
|
WO2014078636A1
(fr)
|
2012-11-16 |
2014-05-22 |
President And Fellows Of Harvard College |
Auto-assemblage d'hydrogel d'acides nucléiques
|
US9655848B2
(en)
|
2012-11-19 |
2017-05-23 |
Technion Research & Development Foundation Limited |
Liposomes for in-vivo delivery
|
EP2732825B1
(fr)
|
2012-11-19 |
2015-07-01 |
Invivogen |
Conjugués d'un agoniste de TLR7 et/ou TLR8 avec un agoniste de TLR2
|
WO2014081849A1
(fr)
|
2012-11-20 |
2014-05-30 |
Phasebio Pharmaceuticals, Inc. |
Formulations de principes actifs pour une libération prolongée
|
WO2014081300A1
(fr)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Liposomes activables par des protéines de canal
|
WO2014081299A1
(fr)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Liposome pouvant être actif
|
EP2922574B1
(fr)
|
2012-11-22 |
2023-05-17 |
Tagworks Pharmaceuticals B.V. |
Groupe clivable par voie chimique
|
EP4074834A1
(fr)
|
2012-11-26 |
2022-10-19 |
ModernaTX, Inc. |
Arn à terminaison modifiée
|
EP2971010B1
(fr)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation et administration de compositions de nucléosides, de nucléotides, et d'acides nucléiques modifiés
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
PT3134131T
(pt)
|
2014-04-23 |
2022-03-24 |
Modernatx Inc |
Vacinas de ácidos nucleicos
|